Abcès: –
palpébral: | 320, 22-23
237, 456-459 |
| Abdomen aigu: | 319, 24-25; 323, 18-19 |
| Ablation par cathéter: | 292, 17 |
| Abstinence alcoolique: | 293, 44-47; 294, 45-46; 305, 40-45; 335, 12-14 |
| Abus sexuel: | 341, 17-18 |
| Accès aux soins: | 297, 48-51; 311, 15-19; 321, 19-20; 334, 13-15 |
Accident:
– domestique:
– ischémique transitoire:
– nucléaire:
– vasculaire cérébral: | 210, 60-60
221, 145; 223, 257; 296, 40-44; 313, 19-21;
315, 6-11
205, 332-336
voir AVC |
| Acétazolamide: | 284, 244-253 |
| Acide acétylsalicylique: | 315, 12-13; 321, 11-12 |
| Acide folique: | 236, 384-391; 246, 344-346 |
| Acide gras oméga 3: | 313, 15-16 |
| Acide hyaluronique: | 227, 475-479 |
Acidose:
– métabolique: | 292, 28-29
301, 36-44 |
Acné:
– rosacée:
– vulgaire: | 220, 67; 309, 14-16
299, 34-39 |
| Activité physique: | 291, 16; 323, 20-23; 325, 15-19 |
| Acuité visuelle: | 228, 528-530 |
| Adalimumab: | 341, 13-16 |
| Addiction: | 299, 44-47; 323, 16-17; 340, 6-10; 348, 18-19 |
| Addison (Maladie d’-): | 239, 24-27 |
Adénocarcinome:
– œsophagien: | 291, 18
263, 201-205 |
| Adénopathie: – médiastinale: | 211, 145; 215, 357; 236, 418-419; 241, 117;
249, 8-13; 251, 127
327, 26-27 |
| Adjuvant: | 346, 18-21 |
| Adolescence: | 208, 490-495; 221, 124-127; 261, 108-110; 261, 116-121;
263, 211; 271, 112-114; 272, 150-151; 285, 288-289;
302, 24-31; 310, 17-19; 319, 16-17; 334, 21-22;
340, 6-10; 344, 22-23 |
| Adrénaline: | 250, 70-74 |
| Aérateur transtympanique: | 331, 11-13 |
| Aérosol: | 199, 8-12; 335, 12-14 |
| Agents biologiques: | 337, 19-20 |
| Agglutinines irrégulières: | 204, 276-277 |
| Agitation: | 220, 91; 229, 8-15; 294, 26; 318, 20-22;
343, 16-17 |
| Agressivité: | 222, 196-198; 309, 25-26 |
| Akinésie: | 217, 448-453 |
| Albuminurie: | 301, 36-44 |
| Alcool: | 209, 37-39; 231, 145; 246, 344-346; 280, 66-67;
282, 160-161; 282, 167; 291, 46-49; 293, 24;
293, 44-50; 295, 8-15; 302, 16-18; 302, 24-31;
303, 18-20; 304, 34-41; 304, 56-59; 305, 40-45;
312, 27-28; 313, 24-25; 314, 6-14; 314, 23-24;
317, 19-20; 320, 22-23; 323, 12-13; 323, 16-17;
324, 10-12; 334, 21-22; 335, 12-14; 347, 18-19;
348, 18-19 |
| Algie vasculaire de la face: | 228, 535 |
| Algodystrophie: | 208, 486-489, 262, 149 |
| Algologie: | 341, 13-16 |
| Alimentation: | 303, 44-49; 308, 30-33; 310, 20-22; 317, 15-16;
322, 16-18; 329, 12-14 |
| Allaitement maternel: | 228, 522-526; 234, 276-284; 302, 24-31; 308, 30-33
320, 17; 334, 21-22; 337, 11 |
| Allergie: – alimentaire:
– de contact:
– médicamenteuse:
– respiratoire: | 213, 253; 232, 168-174; 232, 192-197; 242, 152-156;
250, 70-74; 261, 123; 274, 244-251; 333, 21-22
308, 30-33; 330, 16-17
280, 61
234, 302-309; 331, 6-10
338, 14-16 |
| Allopuriol: | 291, 18 |
| Alopécie: | 219, 35-38; 239, 24-27; 347, 14-15 |
| Altitude: | 284, 244-253 |
| Alzheimer: | 201, 112-116; 258, 424-431; 291, 46-49; 296, 8-18;
300, 22-24; 304, 42-47; 306, 44-48; 317, 6-14;
317, 15-16; 343, 16-17 |
| Amaigrissement: | 343, 23-24 |
| Amaurose: | 226, 410-414; 311, 23-25 |
| Aménorrhée: | 219, 41; 300, 26-34; 316, 23-25 |
| Amiodarone: | 282, 169; 332, 17-21 |
| Ampullome: | 286, 338-339 |
| Analgésie: | 210, 66-67; 228, 510-512; 295, 54-60 |
| Analgésiques morphiniques: | 290, 32-41; 294, 18 |
| Analogues GLP-1 | 312, 6-12 |
| Anaphylaxie: | 307, 8-10; 316, 18-19; 338, 14-16 |
| Anatomopathologie: | 227, 444-451; 227, 464-468 |
| Anémie: | 199, 41; 236, 384-391; 292, 24-25; 292, 28-29;
294, 25-26; 294, 45-46; 294, 48-51; 324, 19-20 |
Anesthésie:
– locale: | 203, 208-212; 231, 120-123; 307, 8-10
210, 66-67 |
Anévrysme:
– de l’aorte abdominale:
– intracrânien: | 297, 24-32
293, 33; 301, 16-18 |
| Angine: | 252, 144-149; 303, 22-23 |
| Angiofibrome: | 329, 15-16 |
| Angio-œdème: | 331, 6-10; 338, 20-24 |
| Angor: | 285, 300-301; 309, 14-16 |
Angiome:
– veineux: | 263, 197
300, 20-21 |
| Anite: | 341, 17-18 |
| Anneau vaginal: | 299, 34-39 |
| Anorexie: | 310, 20-22 |
| Anormalité oculaire: | 305, 18-19 |
| Anosmie: | 332, 24-25 |
| Antalgiques: | 223, 242-250; 228, 510-512; 305, 8-12; 332, 6-11 |
| Antagonistes adrénergiques: | 300, 22-24 |
| Anti-acides: | 332, 12-14 |
| Anti-agrégant plaquettaire: | 262, 156-159; 296, 8-18; 348, 15 |
| Antibioprophylaxie: | 311, 6-10 |
| Antibiotiques: | 202, 178-180; 257, 386-389; 291, 17; 302, 16-18;
305, 8-12; 307, 8-10; 318, 16-17; 319, 16-17;
328, 13-14; 340, 11-13; 340, 23-24 |
| Anticholinestérasiques: | 313, 19-21; 343, 16-17 |
| Anticoagulants: | 209, 28-33; 291, 28-29; 293, 8-20; 296, 8-18;
306, 8-10; 307, 50-52; 319, 20-21; 333, 11-13 |
Anticorps:
– antinucléaires:
– monoclonaux: | 295, 34-43
247, 407; 333, 17-18 |
| Antidépresseurs: | 311, 11-12; 312, 13-14; 316, 20-22; 317, 19-20;
317, 23-24; 326, 11-12; 327, 16-17; 328, 10-12;
330, 16-17; 344, 16-18 |
| Antidiabétiques oraux: | 244, 258-263; 270, 67-69 |
| Anti-épileptiques: | 313, 19-21 |
| Antigènes urinaires: | 281, 122-123 |
| Anti-histaminique: | 223, 233-235 |
| Anti-inflammatoires: | 302, 16-18; 340, 11-13 |
| Antiplaquettaires: | 315, 12-13 |
| Antipsychotiques: | 242, 168-174 |
| Antithyroïdiens: | 341, 13-16 |
| Anti-TNF: | 271, 96-105; 332, 22-23 |
| Antitussif: | 208, 484-485 |
| Antiviraux: | 292, 16; 345, 6-11 |
| Anti-vitamine K: | 293, 8-20 |
| Anus: | 264, 239 |
| Anxiété: | 331, 16-18 |
| Aphtose buccale: | 342, 13 |
| Apnée: | 257, 376-383 |
| Aponévrose plantaire: | 247, 395 |
| Aponévrosite: | 301, 16-18 |
| Apophysose: | 210, 80-85 |
| Appendalgie: | 262, 165 |
| Appendicite: | 289, 20-23; 301, 46-49; 305, 22-28 |
Aptitude
– à la conduite automobile:
– professionnelle:
– sportive: | 344, 16-18
290, 14-16
271, 112-114 |
| Arrachement apophysaire: | 283, 195 |
| Arrêt cardio-respiratoire: | 221, 132-139; 292, 19 |
Artériopathie:
– des membres inférieurs: | 213, 216-222
286, 347 |
| Artérite: | 208, 501; 305, 52-54 |
| Arthralgie: | 292, 32-34; 336, 19-21 |
Arthrite:
– juvénile:
– microcristalline:
– réactionnelle:
– septique: | 298, 44-50; 306, 24-32; 326, 13-14; 327, 26-27
239, 8-15
333, 17-18
258, 435
246, 353-357; 295, 64-66; 298, 44-50 |
| Arthroplastie de hanche: | 303, 26-31 |
| Arthroscopie: | 309, 11-12 |
Arthrose:
– de hanche: | 227, 475-479; 291, 19; 326, 11-12
330, 16-17 |
| Articulation coxo-fémorale: | 239, 8-15 |
| Arythmie: | 209, 28-33; 248, 435 |
| Aspergillus: | 227, 481; 261, 123 |
| Aspirine: | 275, 288-295; 279, 25-30; 281, 96-103; 299, 18-20;
301, 8-15 |
| Assistance par téléphone: | 297, 18-20 |
| Assurance: | 306, 44-48; 338, 19-22 |
| Asthme: | 216, 390-393; 250, 70-74; 261, 123; 268, 413;
274, 244-251; 299, 26-32; 300, 40-46; 316, 18-19;
324, 13-14; 333, 21-22; 337, 21-23; 338, 14-16 |
| Ataxie: | 254, 248-255; 324, 10-12 |
| Athérogenèse: | 237, 469-472 |
| Atopie: | 232, 168-174; 232, 192-197; 318, 16-17; 333, 21-22 |
| Attachement (Troubles de l’-): | 206, 364-368 |
| Attitude: | 199, 38-39 |
| Audition: | 231, 112-117; 231, 128-131 |
| Aura migraineuse: | 313, 19-21 |
| Auto-évaluation: | 204, 282-287 |
| Automutilation: | 319, 16-17 |
| Autonomie: | 242, 179; 309, 17-22; 319, 20-21 |
| AVC: | 212, 184-186; 219, 17-18; 241, 118-120; 293, 23;
296, 40-44; 299, 34-39; 306, 8-10; 315, 6-11;
315, 12-13; 316, 18-19; 321, 11-12 |
| (haut de la page) |
| Baclofène: | 293, 47-50; 302, 24-31; 314, 6-14; 347, 18-19;
348, 18-19 |
| Bactérie multi-résistante: | 322, 6-11 |
| Bactériurie: | 292, 23-24 |
| Balanite: | 269, 35; 292, 23-24; 347, 16-17 |
| Balanoposthite: | 347, 16-17 |
| Balint: | 307, 46-48 |
| Banc solaire: | 300, 16-18 |
| Bandelette ilio-tibiale: | 243, 196-199 |
| Bandelette urinaire: | 292, 27-28 |
| Bartonella: | 251, 127 |
| Benzodiazépines: | 299, 44-47; 300, 22-24; 304, 34-41; 313, 24-25;
317, 15-16; 317, 19-20 |
| Bêta-bloquant: | 310, 13-14; 311, 11-12; 312, 13-14; 325, 20-21 |
| Bêta-lactamase à spectre étendu (BLSE): | 322, 6-11 |
| Bethesda 2001: | 227, 444-451; 227, 464-468 |
| Bigéminisme ventriculaire: | 260, 79 |
Bilan:
– hydrique
– préopératoire:
– santé: | 257, 364-369
231, 120-123
202, 164-166; 301, 16-18 |
| Binge drinking: | 323, 12-13; 323, 16-17; 324, 10-12; 334, 21-22 |
| Biologie clinique: | 256, 320-325; 290, 21-25; 294, 44-45 |
| Biothérapie: | 271, 96-105; 298, 44-50; 333, 17-18 |
| Biphosphonates: | 214, 292-294; 300, 26-34; 324, 19-20 |
| Bisphénol A: | 348, 20-21 |
| Blastocystis hominis: | 297, 54-56 |
| Blépharite: | 311, 23-25 |
| Blépharospasme: | 282, 152-157 |
Bloc:
– A-V:
– de branche droit
– de branche gauche complet: | 221, 128-131
248, 435
199, 26-29 |
| BNP: | 224, 282-285; 306, 24-32 |
| Boiterie: | 229, 22-25; 239, 8-15; 305, 22-28; 308, 30-33 |
| Borréliose: | 274, 255; 284, 228-233; 308, 34-38; 325, 10;
330, 20-22; 337, 14-15 |
| Boulimie: | 310, 20-22 |
| Bowen (maladie de -): | 236, 406-412 |
| BPCO: | 216, 376-382; 216, 390-393; 249, 21; 272, 160-161;
298, 8-18; 298, 20-23; 307, 22-28; 311, 11-12;
312, 13-14; 315, 12-13; 320, 17; 321, 15-16;
324, 13-14; 337, 11 |
| Bronchiectasies: | 218, 498-505 |
| Bronchiolite: | 241, 118-120; 299, 26-32; 335, 12-14; 337, 6-10 |
Bronchite:
– aiguë: | 301, 24-28
310, 13-14 |
| Bronchodilatateur: | 321, 15-16; 337, 6-10 |
| Brugada: | 248, 435 |
Brûlure:
– oculaire: | 203, 229-235; 204, 278-281
226, 410-414 |
| Bulle hémorragique: | 303, 22-23 |
| Buprénorphine: | 216, 396-403; 267, 358-362 |
| Burnout: | 303, 18-20; 305, 14-16; 305, 22-28; 306, 24-32;
315, 21-24; 331, 16-18; 341, 6-12; 348, 20-21 |
| Bursite: | 243, 196-199; 259, 26-29; 290, 18-19 |
| Bypass gastrique: | 307, 30-45 |
| (haut de la page) |
| Café: | 296, 40-44 |
| Calcanéum: | 221, 112-120 |
| Calcémie: | 341, 19-22 |
| Calcitonine: | 208, 486-489 |
| Calcium: | 300, 26-34; 332, 12-14 |
| Calprotectine: | 294, 45 |
Canal:
– carpien:
– lombaire étroit: | 199, 23
264, 228-232; 305, 22-28; 333, 11-13 |
| Cancer: – cervico-facial:
– colique:
– colorectal: – cutané:
– de la prostate: – de l’endomètre:
– du col: – du foie:
– du poumon: – du rein:
– du sein: – gastrique:
– métastasé:
– oropharyngé:
– thyroïdien: | 270, 52-59; 298, 20-23; 311, 11-12; 312, 13-14;
319, 22-23; 321, 6-10; 321, 17-18; 329, 12-14;
332, 22-23
210, 72-73
256, 347
224, 304-307; 259, 8-15; 260, 52-59; 299, 18-20;
313, 22-23
300, 16-18
225, 344-345; 289, 20-23; 292, 29-30; 293, 22;
296, 40-44; 315, 12-13; 315, 16-20
289, 20-23
222, 176-179; 250, 64-65; 300, 26-34; 315, 21-24;
345, 20-21
200, 88-89
275, 317; 290, 14-16; 300, 40-46; 314, 15-16;
315, 12-13; 321, 22-23; 333, 11-13; 335, 20-21
291, 46-49
218, 509; 221, 121; 222, 195; 224, 291; 225, 344-345;
226, 421-423; 240, 64-69; 254, 244-245; 269, 28-30;
301, 16-18; 306, 12-19; 308, 8-10; 312, 17-22;
314, 15-16; 319, 16-17
332, 22-23
315, 12-13
319, 26-27; 324, 13-14
205, 332-336; 270, 70-73 |
| Candida albicans: | 202, 174-177; 269, 35 |
| Candidose: | 336, 13-14 |
| Cannabis: | 208, 490-495; 317, 19-20 |
| Capsulite rétractile: | 225, 350-353 |
Carcinome:
– basocellulaire:
– cuniculatum:
– cutané:
– épidermoïde:
– spinocellulaire: | 206, 397
236, 406-412; 270, 63; 289, 8-19; 289, 24-25
319, 18-19
285, 281
291, 20-21; 319, 18-19
289, 8-19; 291, 20-21 |
| Cardiomyopathie: | 319, 26-27; 331, 23-24 |
| Cardioversion: | 209, 28-33 |
| Carie: | 324, 10-12 |
Carence:
– martiale:
– nutritionnelle: | 199, 41
307, 12-19; 310, 20-22 |
| Carotide: | 306, 8-10 |
| Carré de Whitel | 330, 20-22 |
| Catalepsie: | 292, 54-55 |
| Cataracte: | 226, 388-392; 311, 23-25 |
| CDT: | 282, 160-161 |
| Cécité: | 234, 297-298 |
| Cellulite (péri)orbitaire: | 227, 460-463; 294, 40-43 |
| Céphalée: | 228, 535; 236, 421; 276, 361; 293, 30-31;
294, 54-56; 298, 52-54; 299, 22-24; 308, 52-53;
313, 19-21; 322, 12-13; 326, 23-24; 332, 6-11;
341, 23-24 |
Certificat:
– d’aptitude au sport:
– de décès: | 336, 17-18; 347, 21-23
225, 332-341 + addenda |
| Chagrin: | 290, 14-16 |
| Chalazion: | 237, 456-459 |
| Champ visuel: | 228, 528-530 |
| Chancre: | 286, 343-345 |
| Chaussures: | 313, 15-16 |
| Cheveux: | 219, 35-38 |
| Cheville: | 214, 272-277; 296, 48-55 |
| Chicha: | 263, 184-188 |
| Chikungunya: | 335, 12-14 |
| Chimiothérapie: | 253, 202-209; 315, 12-13; 340, 11-13 |
Chirurgie:
– bariatrique:- esthétique:
– orthopédique:
– thoracique: | 307, 22-28; 338, 11-13
296, 40-44; 303, 44-49; 307, 12-19; 307, 30-45;
309, 23-24; 326, 15-17
220, 85-89
280, 63-65
297, 8-16 |
| Chlamydia trachomatis: | 290, 48-51; 298, 26-29 |
| Chlore: | 274, 244-251 |
| Choc anaphylactique: | 250, 70-74 |
| Choix du patient: | 285, 282-285 |
| Choléra: | 298, 26-29 |
| Cholestase: | 273, 216-221; 286, 338-339 |
| Cholestéatome: | 209, 8-12 |
| Chômage: | 302, 42-44 |
| Chondrocalcinose: | 246, 353-357 |
| Chutes: | 204, 260-264; 275, 317; 286, 326-329; 311, 26-27 |
| Cicatrisation: | 303, 18-20 |
| Cils: | 222, 180-183 |
| Cinquième maladie: | 348, 16-17 |
Cirrhose:
– alcoolique:
– hépatique: | 318, 23-25
200, 88-89; 225, 356-360; 291, 46-49; 291, 52-54;
294, 46; 302, 24-31 |
| Claquage: | 213, 244-246 |
| Clarithromycine: | 311, 11-12; 312, 13-14 |
Claudication:
– intermittente: | 264, 228-232; 286, 347; 305, 22-28
208, 501 |
| Clearance de la créatinine: | 222, 189-191; 283, 200-203 |
| Cloison nasale: | 240, 73 |
| Clopidrogel: | 258, 435 |
| Clostridium difficile: | 298, 26-29 |
| Cluster headache: | 228, 535; 313, 19-21 |
| CMV: | 231, 145; 246, 344-346 |
| Codéine: | 320, 17 |
| Coenzyme Q10: | 322, 12-13 |
| Coiffe des rotateurs: | 228, 500-507; 251, 101-107 |
| Colchicine: | 344, 12-13 |
| Coliques du nourrisson: | 337, 11 |
| Colique néphrétique: | 331, 11-13 |
| Colite spasmodique: | 300, 16-18 |
| Colobome: | 305, 18-19 |
| Côlon irritable: | 300, 16-18; 328, 10-12; 332, 22-23 |
| Colonoscopie: | 224, 304-307; 259, 8-15; 260, 52-59 |
| Colopathie fonctionnelle: | 326, 11-12; 327, 16-17; 328, 10-12 |
| Coma: | 303, 44-49 |
| Communication: | 199, 38-39; 203, 220-221; 212, 173-175; 238, 526-527;
297, 24-32; 312, 17-22; 315, 21-24; 321, 19-20;
336, 22-24 |
| Comorbidité: | 306, 8-10; 306, 24-32; 321, 19-20 |
| Compétence: | 306, 24-32; 314, 21-22 |
| Compliance: | 213, 226-227; 315, 21-24; 315, 21-24 |
| Comportement alimentaire: | 322, 16-18 |
| Compréhension: | 199, 38-39 |
| Compression médullaire: | 289, 48-49 |
| Concertation multidisciplinaire: | 329, 12-14 |
| Conduite addictive: | 305, 40-45 |
| Conduite automobile: | 227, 454-456 |
| Condylome: | 329, 15-16; 345, 20-21 |
| Confiance: | 199, 38-39 |
Conflit:
– radiculaire:
– antérieur de hanche: | 222, 196-198
229, 30-37
232, 198-199 |
| Confusion: | 201, 112-116; 239, 43; 296, 58-61; 344, 16-18 |
Conjonctivite:
– allergique: | 325, 11-12
311, 23-25; 338, 14-16 |
| Conjonctivochalasis: | 340, 19-20 |
Conseil:
– hygiéno-diététique:
– minimal | 311, 6-10
252, 157-158; 272, 147-148; 272, 183 |
| Consommation d’alcool: | 293, 44-49; 305, 40-45; 313, 24-25 |
| Constipation: | 200, 91; 301, 16-18; 329, 12-14; 330, 16-17 |
Consultation:
– complexe: | 214, 280-281; 297, 24-32
309, 11-12 |
Contention:
– physique: | 303, 26-31
294, 26 |
| Continuité des soins: | 346, 15 |
| Contraception: | 213, 226-227; 221, 124-127; 293, 24; 296, 8-18;
298, 20-23; 299, 34-39; 316, 23-25; 325, 13-14 |
| Contusion: | 203, 229-235 |
| Convulsions: | 329, 12-14 |
| Coqueluche: | 220, 70-73; 266, 321-323; 333, 23-24 |
| Cordon fibreux: | 327, 18-19 |
| Cornée: | 204, 278-281; 259, 19 |
| Corps étranger: | 203, 229-235; 259, 19 |
Corticoïdes:
– inhalés: | 331, 14-15
301, 16-18 |
| Corticothérapie: | 275, 304-306; 300, 22-24; 320, 17 |
| Cosmétique: | 259, 22-23 |
| Cotinine: | 251, 112-115; 272, 162-165 |
| Coude: | 296, 48-55 |
| Couple: | 215, 346-352 |
| Coups et blessures (constat de -): | 237, 440-447 |
| Coxa plana: | 229, 22-25 |
| Coxsackie: | 205, 328-331 |
| Craving: | 305, 40-45 |
| Créatinine sérique: | 292, 28-29 |
| Critères d’Ottawa: | 312, 23-24 |
Croissance:
– staturale: | 220, 60-66
301, 16-18 |
| Cruralgie: | 305, 52-54 |
| Cryothérapie: | 329, 12-14 |
| Cryptorchidie: | 247, 380-385 |
| Curetage: | 329, 12-14 |
| Cycle menstruel: | 326, 18-22 |
| Cystite: | 292, 23-24; 311, 6-10 |
| Cytolyse: | 273, 216-221; 277, 405; 325, 22-23 |
| (haut de la page) |
| Datura: | 273, 211 |
| D-dimères: | 246, 363 |
| Décision médicale: | 315, 21-24; 334, 17-18 |
| Décision partagée: | 347, 18-19 |
| Déchirure musculaire: | 213, 244-246 |
| Déclaration obligatoire: | 274, 266-267; 274, 270; 277, 401; 278, 447;
298, 32-38 |
Décollement:
– apophysaire:
– de la rétine:
– postérieur du vitré | 222, 164-173; 223, 220-228
311, 23-25
311, 23-25 |
| Décompensation cardiaque: | 199, 26-29; 295, 54-60; 314, 15-16 |
| Décontamination: | 218, 480-485 |
| Déclin fonctionnel: | 299, 26-32 |
| Défibrillateur: | 325, 20-21 |
| Défibrillation précoce: | 221, 132-139 |
Déficit cognitif:
– modéré: | 296, 8-18; 309, 17-22
310, 13-14 |
| Déficit d’extension d’une main: | 338, 17-18 |
| Dégénérescence maculaire liée à l’âge (DMLA): | 328, 17-21 |
| Délire: | 264, 241; 299, 26-32 |
| Delirium: | 320, 22-23 |
| Démence: – sénile: | 201, 112-116; 294, 17; 297, 18-20; 304, 42-47;
307, 8-10; 309, 17-22; 310, 13-14; 311, 11-12;
312, 13-14; 313, 19-21; 317, 6-14; 317, 15-16;
318, 20-22; 319, 20-21; 323, 20-23; 340, 18;
344, 16-18
311, 26-27 |
| Dénervation sympathique: | 301, 30-35 |
| Dengue: | 298, 26-29; 315, 25-26 |
| Déni: | 202, 156-160 |
| Densitométrie osseuse: | 213, 236-238; 293, 24; 300, 26-34; 303, 8-17;
304, 8-24 |
| Dents: | 324, 10-12 |
| Dénutrition: | 289, 34-41; 295, 54-60; 307, 22-28 |
| Déontologie: | 204, 268-272 |
| Dépendance: – au jeu: | 232, 178-180; 299, 44-47; 304, 56-59; 306, 44-48;
317, 19-20
325, 13-14 |
| Dépistage: – cardiovasculaire:
– du cancer:
– neurosensoriel:
– prénatal non invasif: | 202, 170-172; 218, 509; 222, 195; 224, 291;
224, 304-307; 225, 344-345; 226, 421-423; 243, 202-203;
254, 244-245; 260, 52-59; 266, 338-340; 270, 70-73;
297, 24-32; 298, 20-23; 308, 40-51; 312, 17-22;
313, 15-16; 315, 16-20; 315, 21-24; 322, 12-13;
323, 20-23; 336, 13-14
236, 395-396; 309, 14-16
290, 14-16; 309, 11-12; 319, 16-17; 321, 17-18
323, 20-23
323, 20-23 |
| Dépression: – bipolaire:
– de la personne âgée: | 200, 60-64; 209, 41; 232, 201; 233, 259-261;
241, 126-130; 242, 179; 270, 79; 279, 37;
294, 17; 294, 26-27; 297, 18-20; 302, 16-18;
306, 24-32; 309, 11-12; 311, 11-12; 312, 13-14;
317, 23-24; 331, 16-18; 336, 13-14; 348, 20-21
282, 140-145; 344, 12-13
344, 16-18 |
Dermatite:
– atopique:
– périorale:
– séborrhéique:
– atopique: | 322, 19-21
331, 14-15
319, 16-17
217, 438-440; 232, 168-174 |
| Dermatologie: | 297, 24-32; 307, 22-28; 338, 20-24 |
| Dermatophytose: | 282, 149; 311, 13-14; 344, 14-15 |
Dermatose:
– cendrée:
– héréditaire:
– transitoire: | 332, 12-14
230, 78-81
336, 15-16
337, 12-13 |
| Dermite des chaufferettes: | 226, 404-407 |
| Dermocorticoïdes: | 323, 12-13 |
| Désensibilisation: | 242, 152-156; 338, 14-16 |
| Déshydratation: | 239, 43; 301, 24-28; 338, 19-22 |
| Désinsertion tendineuse: | 200, 69 |
| Détresse respiratoire: | 304, 42-47 |
| Deuil: | 211, 112-119; 317, 23-24 |
| Développememnt durable: | 209, 16-17 |
| Développement ectopique mélanocytaire: | 340, 14-15 |
| Diabète: – gestationnel: | 205, 322-325; 213, 216-222; 235, 350-355; 244, 258-263;
266, 328-333; 268, 410-411; 269, 35; 270, 67-69; 271, 123;
279, 8-15; 279, 25-30; 284, 240-241; 285, 304-306;
296, 40-44; 301, 8-15; 305, 14-16; 306, 8-10;
309, 14-16; 310, 13-14; 312, 6-12; 319, 20-21;
321, 15-16; 323, 20-23; 324, 13-14; 329, 12-14;
334, 10; 335, 12-14; 335, 20-21; 336, 13-14;
338, 19-22; 340, 18; 348, 15
319, 16-17 |
| Diagnostic: | 336, 22-24 |
| Diapneusie: | 338, 12-13 |
| Diarrhée: – chronique:
– médicamenteuse: | 209, 41; 235, 361-363; 237, 460-463; 297, 54-56;
298, 26-29
247, 407; 268, 429; 309, 14-16
341, 13-16 |
| Diphtérie: | 206, 372-374; 220, 70-73 |
| Diplopie: | 228, 528-530; 291, 38-44; 303, 52-55; 341, 23-24 |
| Disponibilité: | 214, 280-281 |
Dispositif:
– intra-utérin:
– transdermique hormonal: | 299, 34-39; 345, 22-24
299, 34-39 |
| Dissection aortique: | 201, 139 |
| Disulfirame: | 293, 47 |
| Diurétiques: | 211, 124-126; 301, 36-44; 310, 13-14; 332, 12-14 |
| Diversification alimentaire: | 333, 21-22 |
| Diverticulite: | 257, 391; 338, 11-13 |
| DMLA: | 311, 23-25 |
| Doigt en maillet: | 200, 69 |
| Dopage: | 216, 386-387 |
| Dopamine: | 329, 12-14 |
| Dorsalgies: | 204, 293; 205, 347; 307, 20-21 |
| Dosage urinaire: | 279, 20-21 |
Dossier médical:
– global:
– G+:
– informatisé: | 206, 390-393; 210, 89-91; 307, 22-28
281, 108-109
281, 112-113; 308, 40-51
235, 343-344; 240, 84-89; 249, 16-17 |
| Douleur: – abdominale: – anale:
– articulaire:
– chronique:
– du pied:
– inguinale:
– musculaire:
– musculosquelettique:
– neuropathique:
– oculaire:
– pelvienne:
– post-zostérienne:
– scapulaire:
– thoracique: | 210, 66-67; 228, 510-512; 290, 32-41; 290, 44-45;
340, 11-13; 345, 18-19
214, 311; 216, 411; 238, 528-529; 257, 391;
262, 165; 284, 255; 289, 20-23; 297, 54-56;
301, 46-49; 305, 22-28; 309, 27-28; 326, 11-12;
327, 16-17; 328, 22-23; 336, 19-21
343, 16-17
270, 79; 308, 30-33
223, 242-250
328, 13-14
305, 52-54
293, 26-27
274, 271
223, 242-250; 247, 400-405
325, 11-12
261, 96-103
341, 13-16
305, 22-28
218, 488-491; 249, 35; 297, 24-32; 302, 46-49 |
| Drogues: | 279, 20-21 |
| Droits du patient: | 203, 220-221; 304, 42-47 |
| DSM IV: | 241, 126-130 |
| Dysautonomie: | 252, 169 |
| Dysfonction érectile: | 293, 23; 303, 32-41 |
| Dyshidrose: | 320, 18-19 |
| Dyslipidémie: | 225, 344-345 |
| Dysménorrhée: | 326, 18-22 |
| Dyspareunie: | 245, 315 |
| Dysphagie: | 294, 54-56 |
| Dysphonie: | 321, 22-23 |
Dysplasie:
– cervicale:
– coxo-fémorale: | 300, 26-34
232, 198-199 |
| Dyspnée: | 199, 41; 203, 229-235; 221, 128-131; 259, 35;
261, 107; 268, 413; 295, 54-60; 301, 24-28;
306, 24-32; 307, 22-28; 322, 12-13 |
Dystonie:
– de fonction: | 282, 152-157
238, 512-521 |
| Dystrophie unguéale: | 308, 26-27 |
| (haut de la page) |
| EBM: | 202, 178-180; 211, 124-126; 225, 344-345; 231, 138-140;
245, 307-309; 262, 140-145; 297, 34-46; 300, 26-34;
301, 8-15; 306, 34-41; 314, 21-22; 321, 19-20 |
| E-cigarette: | 278, 436-439; 325, 13-14; 333, 6-10 |
| Ecchymose: | 218, 511 |
| Echauffement musculaire: | 298, 20-23 |
| Echec thérapeutique: | 291, 17 |
| Echelonnement: | 321, 19-20 |
| Echocardiographie: | 306, 24-32 |
| Echographie: | 305, 22-28; 347, 6-13 |
| Eclampsie: | 305, 22-28 |
| Economie de la santé: | 334, 17-18 |
| Ecoute: | 199, 38-39; 200, 82-84; 212, 173-175; 214, 280-281 |
| Ecthyma: | 312, 15-16 |
| Eczéma: – atopique:
– de contact:
– séborrhéique: | 232, 168-174; 232, 192-197; 246, 349; 250, 67;
253, 199; 274, 244-251; 320, 18-19; 333, 21-22
304, 34-41; 323, 12-13
276, 345; 280, 61
319, 16-17 |
| Education à la santé: | 200, 82-84; 298, 8-18; 323, 20-23 |
| Effet atopinique: | 273, 211 |
| Effet iatrogène: | 302, 16-18; 304, 26-28; 304, 30-31; 308, 52-53;
326, 11-12; 328, 10-12 |
| Effets indésirables: | 255, 276-281; 259, 22-23; 302, 32-40; 308, 52-53 |
| Effets secondaires: | 199, 30-34; 200, 82-84; 318, 16-17 |
| Ejaculation prématurée: | 290, 8-13; 291, 8-15 |
| Electrocardiogramme (ECG): | 221, 128-131; 232, 186-189; 248, 435; 316, 6-13;
336, 17-18; 341, 19-22; 347, 21-23 |
| Electrolytes: | 341, 19-22 |
| Elongation: | 213, 244-246 |
Embolie:
– pulmonaire: | 345, 12
201, 122-124; 246, 363; 293, 24 |
Embolisation:
– thérapeutique: | 230, 86-91
293, 33 |
| Emotions: | 237, 475-476; 309, 25-26 |
| Empathie: | 219, 8-13; 237, 475-476; 238, 526-527; 290, 14-16;
302, 16-18; 315, 21-24 |
Encéphalite:
– à tiques:
– japonaise: | 298, 26-29; 308, 34-38
298, 26-29 |
| Encéphalopathie: | 312, 27-28 |
| Encodage: | 210, 89-91; 240, 84-89 |
| Endobrachyœsophage: | 263, 201-205 |
| Endocardite: | 256, 347 |
| Endomètre: | 289, 20-23 |
| Endométriose: | 261, 96-103 |
| Endoscopie: | 335, 20-21 |
| Enfant: | 332, 6-11 |
| Engelure: | 207, 432-435 |
| Enseignement: | 335, 17-19 |
| Entérite: | 294, 45 |
Entorse:
– de cheville:
– de poignet:
– du genou: | 214, 272-277; 241, 118-120; 312, 23-24
219, 24-27
222, 164-173; 223, 220-228 |
| Entretien motivationnel: | 295, 8-15 |
| Enurésie nocturne: | 206, 382-388; 292, 19 |
| Environnement: | 211, 122-123; 332, 22-23 |
| Epanchement articulaire: | 202, 188-189; 259, 26-29; 323, 14-15 |
| Epaule: | 228, 500-507; 251, 101-107; 266, 325; 305, 22-28 |
| Epicondylalgie: | 240, 74-80 |
| Epidémie de grippe: | 243, 223 |
| Epidémiologie: | 219, 17-18 |
| Epigastralgies: | 232, 186-189; 323, 18-19; 326, 23-24 |
| Epiglottite: | 316, 18-19 |
| Epilepsie: | 231, 145; 316, 18-19 |
| Epithelioma spinocellulaire: | 285, 281 |
| Epistaxis: | 240, 73 |
| Epuisement professionnel: | 329, 6-11; 348, 20-21 |
| Erection: | 315, 12-13 |
| Ergonomie: | 283, 186-191 |
Erosion:
– articulaire | 204, 278-281; 259, 19
271, 96-105 |
Erreur:
– médicale: | 297, 24-32
338, 19-22; 342, 23-24 |
| Eruption: – bulleuse:
– cutanée:
– érythémateuse:
– pédiatrique:
– vésiculeuse: | 200, 78-81; 211, 128-131; 218, 494-497; 220, 74-77;
226, 404-407; 227, 460-463; 230, 78-81; 231, 124-127;
233, 240-243; 235, 347-348; 239, 24-27; 241, 117;
243, 209; 287, 371; 311, 13-14; 316, 16-17;
331, 6-10; 332, 15-16; 346, 23-24
238, 506-509; 322, 14-15
315, 25-26; 338, 14-15
213, 230-233
348, 16-17
205, 328-331 |
| Erysipèle: | 245, 299; 335, 12-14 |
Erythème:
– infectieux:
– migrant:
– noueux:
– polymorphe majeur: | 202, 174-177
233, 240-243
325, 10
280, 81; 346, 23-24
251, 111 |
| Erythropoïétine: | 292, 24-25 |
| Escarres: | 342, 6-12 |
| Etat de choc: | 305, 22-28 |
| Ethinylestradiol: | 299, 34-39 |
| Ethique: | 230, 64-67; 266, 336-337; 266, 338-340; 323, 20-23;
329, 12-14; 333, 11-13; 336, 6-12; 340, 11-13 |
| Euthanasie: | 230, 60-63; 230, 64-67; 230, 82-84; 304, 42-47;
340, 18 |
Evaluation:
– des risques:
– gériatrique: | 199, 16-20; 209, 22-23; 230, 70-72; 279, 33-35
302, 32-40
309, 6-10 |
Examen:
– clinique:
– complémentaire: | 329, 17-19
329, 17-19 |
| Exanthème: | 332, 15-16 |
| Excrétion rénale: | 321, 15-16 |
| Exenatide: | 266, 328-333 |
| Exercice physique: | 310, 13-14; 325, 15-19 |
| Exophtalmie: | 226, 388-392; 294, 20-22 |
| Expectoration: | 218, 498-505; 294, 44-45 |
| Extenseur du doigt: | 200, 69 |
Extrasystole:
– ventriculaire: | 265, 281
325, 20-21 |
| (haut de la page) |
Facteur de risque:
– cardiovasculaire:
– des chutes:
– génétique: | 204, 293; 333, 11-13
204, 260-264
336, 13-14 |
| Facteur rhumatoïde: | 333, 17-18 |
| Facteurs socio-économiques: | 296, 8-18 |
| Faiblesse musculaire: | 291, 38-44 |
| Famille: | 215, 346-352 |
| FAN: | 333, 17-18 |
Fasciite:
– nécrosante:
– plantaire: | 301, 16-18
335, 12-14
328, 13-14 |
| Fatigue: | 200, 60-64; 231, 138-140; 261, 107; 325, 22-23 |
| Fécondation: | 248, 438-445 |
| Feed-back: | 199, 38-39 |
| Fer: | 294, 48-51; 310, 20-22 |
| Ferritine: | 294, 49-50; 310, 20-22 |
| Fertilité: | 248, 438-445 |
| Fibrates: | 301, 36-44 |
| Fibrillation auriculaire: | 206, 378-381; 207, 449; 209, 28-33; 212, 178-181;
225, 369; 256, 340-343; 260, 79; 281, 96-103;
291, 28-29; 292, 17; 293, 23; 306, 8-10; 309, 27-28;
324, 13-14; 333, 11-13; 342, 23-24; 348, 15 |
| Fibrokératome: | 308, 26-27 |
| Fibromyalgie: | 215, 324-333; 279, 37; 316, 14-15 |
| Fibroscan® | 338, 6-10 |
| Fibrose hépatique: | 291, 46-49; 291, 52-54; 338, 6-10; 345, 6-11 |
| Fiche informative: | 276, 332-339 |
| Fièvre: – boutonneuse:
– jaune:
– nue:
– prolongée:
– typhoïde: | 215, 357; 216, 406-408; 264, 255; 265, 297;
317, 23-24; 329, 12-14; 338, 19-22; 343, 16-17;
344, 6-11
292, 32-34
298, 26-29
348, 6-14
348, 6-14
298, 26-29 |
| Financement: | 307, 22-28 |
| Fin de vie | 301, 24-28; 304, 42-47 |
| Fissure anale: | 343, 16-17 |
| Fléchisseur profond du doigt: | 200, 69 |
| Flore intestinale: | 324, 17-18 |
| Flutter auriculaire: | 199, 26-29 |
| Focus group: | 292, 38-47 |
| Fonction ovarienne: | 324, 6-9 |
| Foramen ovale: | 296, 40-44 |
Formation:
– continue: | 298, 40-42; 299, 40-42; 323, 20-23
200, 70-72; 224, 276-279; 279, 33-35; 293, 36-39;
295, 46-53; 297, 18-20; 302, 16-18; 305, 14-16;
331, 11-13 |
| Formule de Cockroft: | 222, 189-191 |
Fracture:
– de stress:
– du col fémoral:
– du trochiter: | 300, 26-34; 303, 8-17; 304, 8-24; 332, 12-14
221, 112-120; 242, 161
295, 54-60; 326, 11-12; 328, 10-12
266, 325 |
| Fragilité: | 299, 26-32; 309, 6-10 |
| Froid: | 318, 16-17 |
| Frottis cervical: | 206, 397; 222, 176-179; 227, 444-451; 227, 464-468;
250, 64-65; 296, 8-18; 299, 34-39; 300, 26-34;
313, 15-16; 315, 21-24 |
| FSH: | 300, 26-34; 324, 6-9 |
| (haut de la page) |
| Gabapentine: | 299, 18-20 |
| Galactorrhée: | 333, 14-16 |
Gale:
– commune:
– norvégienne: | 228, 533; 304, 34-41; 322, 19-21
228, 518-521
215, 340-343 |
| Ganglion sentinelle: | 236, 418-419 |
| Garde: – de nuit: | 297, 18-20; 297, 24-32; 299, 18-20; 307, 22-28;
317, 15-16; 346, 15
274, 259-262 |
| Gastrectomie: | 307, 30-45 |
| Gastrite chronique: | 332, 22-23 |
| Gastro-entérite: | 286, 316-321 |
| Gastroparésie: | 309, 14-16 |
| Gastroplastie: | 208, 468-473 |
| Genou: – varum/valgum: | 202, 188-189; 222, 164-173; 226, 417-419; 259, 26-29;
296, 48-55; 322, 19-21
334, 06-09 |
| Gériatrie: | 232, 201; 237, 460-463; 245, 296-297; 262, 150-152;
270, 79; 281, 96-103; 286, 326-329; 294, 24-27;
296, 58-61; 297, 24-32; 300, 22-24; 303, 44-49;
305, 30-38; 307, 22-28; 307, 46-48; 328, 6-9;
334, 10; 336, 22-24; 338, 19-22; 340, 11-13 |
| Gestion des soins: | 295, 22-30; 297, 24-32; 308, 8-10 |
| GHB: | 348, 18-19 |
| Giardia: | 297, 54-56 |
Glande:
– mammaire surnuméraire:
– sébacée:
– sudoripare: | 288, 415
342, 18-19
333, 19-20 |
| Glaucome: | 226, 410-414; 292, 17; 324, 10-12 |
| GLEM: | 199, 16-20, 230, 70-72 |
| Glitazones: | 327, 20-25 |
| Glomérulonéphrite: | 301, 36-44 |
| Glosso-pharyngien: | 201, 132-137 |
| Gluten: | 235, 332-339; 347, 14-15 |
| GNA: | 252, 144-149 |
| Gonalgie: | 312, 23-24; 338, 11-13 |
| Gonarthrose: | 309, 11-12 |
| Goutte: | 246, 353-357; 291, 18; 298, 44-50; 301, 36-44;
303, 18-20; 310, 13-14; 333, 17-18; 344, 12-13 |
| Grains de Fordyce: | 342, 18-19 |
| Granulome: | 316, 16-17 |
| Graves-Basedow | 306, 56-61 |
| Greffe: | 303, 44-49 |
Grippe:
– A H1N1: | 265, 297; 277, 405; 325, 6-9; 345, 15-16
267, 366-367 |
| Grossesse: – extra-utérine | 204, 276-277; 234, 276-284; 246, 332-341; 246, 344-346;
269, 08-12; 272, 172-179; 292, 18; 293, 24; 295, 16-21;
299, 34-39; 302, 24-31; 304, 26-28; 305, 8-12;
305, 14-16; 305, 22-28; 316, 14-16; 324, 19-20;
332, 12-14; 334, 21-22; 336, 13-14; 340, 11-13;
342, 13
254, 257; 305, 22-28 |
| Guêpe (piqûre de -): | 230, 93 |
| (haut de la page) |
| Halonaevus: | 297, 22-23 |
| Hamartochondrome: | 330, 23-24 |
Hamartome:
– sébacé de Jadassohn: | 330, 23-24
258, 408-414 |
| Hanche: | 316, 26-27 |
| Handicap mental: | 271, 123 |
| Hantavirus: | 281, 116-119; 281, 125 |
| HbCO: | 265, 284-288; 272, 166-170 |
| HBPM: | 201, 122-124; 296, 8-18; 317, 23-24 |
| Hélicobacter pylori: | 229, 41; 292, 50-53; 332, 22-23 |
| Hémangiome infantile: | 300, 22-24; 328, 10-12 |
Hématome:
– épidural:
– rétro-hyaloïdien:
– rétro-péritonéal:
– sous-dural: | 240, 73
322, 19-21
234, 297-298
305, 22-28
300, 50-52 |
| Hématurie: | 288, 404-411; 328, 22-23; 347, 14-15 |
| Hémoccult: | 260, 52-59; 309, 11-12 |
| Hémochromatose: | 294, 49-50 |
| Hémoglobine glycosylée: | 279, 8-15; 305, 14-16 |
| Hémoptysie: | 330, 23-24; 343, 23-24 |
| Hémorragie: | 254, 257; 301, 24-28; 316, 18-19 |
| Hémostase: | 274, 271 |
| Héparine: | 294, 46; 306, 8-10; 334, 10 |
Hépatite:
– aiguë:
– alcoolique:
– C:- chronique:
– E:
– médicamenteuse:
– virale: | 273, 229; 277, 405; 281, 116-119; 281, 125
325, 22-23
291, 46-49; 302, 24-31; 318, 23-25
200, 88-89; 205, 312-317; 289, 20-23; 292, 16;
322, 12-13; 345, 6-11
289, 20-23
309, 14-16; 325, 22-23; 338, 11-13
273, 216-221; 340, 23-24
292, 16 |
Hernie:
– discale:
– hiatale:
– inguinale:
– ombilicale:
– sous-cutanée: | 229, 30-37; 309, 11-12
199, 41; 323, 18-19
305, 22-28
281, 107
335, 15-16 |
Herpès:
– circiné:
– génital: | 311, 13-14
296, 46-47 |
| HHV8: | 328, 15-16 |
| Hidrosadénite suppurée: | 341, 13-16 |
| HIV: | 250, 56-61; 252, 159; 328, 15-16 |
| HOMA: | 284, 240-241 |
| Homocystéine: | 295, 34-43; 302, 16-18 |
| Hormone parathyroïdienne: | 294, 28-36 |
| Hormonothérapie: | 220, 85-89; 253, 202-209 |
| Hospitalisation: | 262, 150-152 |
| Horton: | 226, 410-414 |
| HPV: | 222, 176-179; 245, 294-295; 300, 26-34; 313, 15-16;
319, 26-27 |
| HTAP: | 259, 35 |
| Hydronéphrose: | 205, 347 |
Hygiène:
– buccodentaire
– des soins: | 340, 11-13
264, 242-245 |
| Hygroma coude: | 290, 18-19 |
| Hymen: | 245, 315 |
| Hyperactivité: | 238, 496-500 |
| Hypercalcémie: | 292, 18; 294, 28-36 |
| Hypercalciurie: | 288, 404-411; 292, 25 |
Hypercholestérolémie:
– familiale: | 297, 24-32; 315, 21-24
332, 22-23 |
| Hypercoagulabilité: | 265, 270-274 |
| Hyperglycémie postprandiale: | 237, 469-472 |
| Hyperhydrose: | 244, 253; 244, 255; 282, 152-157 |
| Hyperkaliémie: | 301, 36-44; 311, 20-22 |
| Hyperkératose: | 215, 340-343 |
| Hyperlipémie postprandiale: | 237, 469-472 |
| Hyperménorrhée: | 294, 50 |
| Hyperoxalurie: | 292, 25 |
| Hyperparathyroïdie: | 292, 18; 338, 19-22 |
| Hyperphagie: | 310, 20-22 |
| Hyperphosphatémie: | 294, 28-36 |
| Hyperprolactinémie: | 333, 14-16; 338, 19-22 |
| Hypersensibilité: | 331, 6-10 |
| Hypersomnie: | 241, 108-113 |
| Hypersplénisme: | 294, 46 |
Hypertension:
– artérielle:- oculaire: | 209, 22-23; 209, 24-27; 211, 124-126; 217, 428-434;
225, 344-345; 230, 70-72; 233, 224-228; 243, 223;
260, 79; 281, 96-103; 287, 360-366; 288, 427-431;
299, 26-32; 300, 16-18; 301, 30-35; 316, 14-15;
319, 20-21; 332, 12-14; 334, 17-18; 335, 12-14;
348, 15
292, 17 |
| Hyperthermie: | 216, 406-408; 235, 365; 329, 20-21 |
| Hypertrichose: | 306, 20-23 |
| Hyperthyroïdie: | 282, 169; 292, 8-14; 294, 20-22; 342, 13 |
| Hypertrophie gingivale: | 330, 18-19 |
| Hypertrophie ventriculaire gauche: | 209, 24-27 |
| Hyperuricémie: | 291, 18; 298, 44-50; 301, 36-44; 303, 18-20; 310, 13-14 |
| Hypnotiques: | 244, 240-243 |
| Hypoacousie: | 236, 421 |
| Hypocalcémie: | 294, 28-36 |
| Hypochondre gauche: | 283, 213 |
| Hypocondrie: | 237, 477 |
| Hypodermite nodulaire subaiguë migratrice: | 298, 24-25 |
| Hypofertilité: | 320, 6-16 |
| Hypoglycémie: | 335, 12-14; 336, 13-14 |
| Hypolipidémiants: | 239, 30-35 |
| Hypomélanose idiopathique en gouttes: | 286, 325 |
| Hyponatrémie: | 257, 364-369; 275, 317; 296, 58-61; 330, 16-17 |
| Hypophosphatémie: | 294, 28-36 |
| Hypopigmentation maculaire: | 286, 325 |
| Hypoplasie mammaire: | 301, 20-21 |
| Hyposialie: | 324, 17-18 |
| Hypotension: | 287, 393; 305, 22-28; 310, 13-14 |
| Hypothyroïdie: | 292, 8-14; 306, 56-61; 331, 11-13 |
| Hystérie: | 268, 402-406 |
| (haut de la page) |
| Iatrogénicité: | 239, 43; 247, 407; 258, 435; 273, 229; 279, 37;
287, 393; 288, 439; 310, 13-14; 311, 20-22;
322, 14-15; 324, 21-22; 330, 16-17; 332, 17-21;
335, 12-14; 338, 14-15; 340, 23-24 |
| Ictère: | 318, 23-25 |
| Ictus amnésique: | 313, 19-21 |
| IEC: | 332, 12-14 |
IgA:
– anti-endomysium:
– anti-transglutaminase: | 235, 332-339
235, 332-339 |
| Iléocolite: | 294, 45 |
| Imagerie médicale: | 293, 29-35; 312, 23-24; 319, 22-23; 323, 6-11 |
| Immigration: | 297, 24-32 |
| Immunomodulateurs: | 217, 438-440 |
| Immunosuppresseurs: | 337, 19-20 |
| Immunothérapie: | 333, 21-22; 337, 19-20 |
Impétigo:
– bulleux: | 322, 19-21; 346, 16-17
214, 288-291 |
| Impuissance: | 315, 12-13 |
| Implant cochléaire: | 231, 128-131 |
| Implant hormonal: | 299, 34-39 |
| Incapacité professionnelle: | 290, 14-16; 302, 42-44 |
| Incertitude: | 315, 21-24; 336, 22-24 |
| Incidentalome: | 333, 14-16 |
| Incision: | 203, 208-212 |
| Inconscient: | 226, 398-399 |
Incontinence:
– anale:
– urinaire: | 264, 239
219, 28-34; 292, 25-27; 302, 8-15 |
| Incrétines: | 266, 328-333 |
| Incrétinomimétiques: | 327, 20-25 |
| Indigence: | 296, 8-18 |
| Industrie pharmaceutique: | 297, 18-20 |
| Inégalités sociales: | 276, 348-351; 323, 20-23; 324, 13-14; 331, 19-20 |
| Inertie thérapeutique: | 299, 26-32 |
| Infarctus: – omental:
– rénal:
– splénique: | 204, 293; 205, 243-344; 232, 186-189; 285, 300-301;
316, 18-19; 324, 13-14
284, 255
283, 213
309, 27-28 |
Infection:
– fongique:
– nosocomiale:
– respiratoire:- urinaire: | 300, 16-18; 307, 22-28
344, 14-15
264, 242-245
291, 17; 301, 24-28; 307, 22-28; 313, 15-16;
340, 11-13
240, 91; 265, 297; 292, 23-24 |
| Infiltration: – intra-articulaire: | 199, 23; 204, 291; 227, 475-479
229, 30-37; 305, 22-28
335, 20-21 |
| Inflammation: | 294, 45-46 |
| Informatique médicale: | 210, 89-91; 240, 84-89; 249, 16-17; 333, 11-13 |
| Infraction: | 338, 19-22 |
| Inhalation sèche: | 199, 8-12 |
Inhibiteurs :
– calciques:
– de la pompe à protons:
– de l’enzyme de conversion: | 311, 11-12; 312, 13-14
voir IPP
voir IEC |
| Injection intramusculaire: | 342, 14-17 |
| INR: | 293, 8-20 |
| Insecte: | 220, 74-77 |
| Insomnie: | 241, 108-113; 244, 240-243; 294, 16-17; 294, 18;
304, 34-41; 327, 6-15; 331, 16-18; 344, 16-18 |
| Institutionnalisation des personnes âgées: | 255, 295-297 |
| Insuffisance cardiaque: | 224, 282-285; 225, 369; 243, 212-217; 280, 78-79;
295, 54-60; 298, 20-23; 306, 24-32; 345, 12 |
| Insuffisance hépatique: | 291, 46-49 |
| Insuffisance rénale: – aiguë:
– chronique: | 291, 46-49; 292, 24-25; 301, 36-44; 311, 20-22;
329, 17-19; 335, 12-14; 343, 6-15
281, 116-119; 281, 125; 302, 16-18; 304, 26-28
283, 200-203; 292, 28-29 ; 310, 6-12; 335, 6-11 |
| Insuffisance veineuse: | 303, 26-31 |
| Insuline: | 244, 258-263; 270, 67-69; 312, 6-12 |
| Insulinorésistance: | 237, 469-472; 284, 240-241 |
| Insulinothérapie: | 338, 19-22 |
| Interaction médicamenteuse: | 303, 18-20; 304, 34-41; 307, 8-10; 329, 17-19;
330, 16-17 |
| Interféron: | 205, 312-317 |
| Intertrigo: | 218, 494-497 |
Intervention:
– brève:
– de crise:
– précoce: | 302, 16-18; 314, 23-24; 317, 19-20; 347, 18-19
300, 8-15
340, 6-10 |
| Intolérance glucidique: | 310, 13-14 |
| Intoxication alimentaire: | 274, 270; 335, 22-23 |
| Intuition: | 310, 26-27; 338, 6-11 |
| IPP: | 222, 184-186; 263, 201-205; 318, 16-17; 332, 12-14 |
| Iris: | 305, 18-19 |
| Irradiation: | 205, 332-336; 319, 22-23; 341, 13-16 |
| Irritation: | 284, 237 |
| Ivermectine: | 215, 340-343 |
| IVG: | 269, 08-12 |
| (haut de la page) |
| Jeunes: | 340, 6-10 |
| Juge de paix: | 344, 16-18 |
| (haut de la page) |
| Kaliémie: | 292, 28-29; 341, 19-22 |
| Kawasaki: | 338, 19-22 |
| Kératoacanthome: | 285, 281 |
Kératose:
– actinique: | 236, 406-412
289, 8-19 |
| Kératolyse ponctuée plantaire: | 244, 253 |
Kinésithérapie:
– respiratoire: | 241, 118-120
194, 248-252 |
Kyste:
– arthro-synovial:
– articulaire:
– mucineux:
– mucoïde:
– poplité: | 204, 291
307, 20-21
255, 285
277, 387
259, 26-29; 309, 13 |
| |
| Laminectomie: | 305, 22-28 |
| Langage: | 231, 112-117; 231, 128-131 |
Larmoiement:
– chronique: | 289, 20-23
254, 243 |
| Larynx: | 210, 72-73 |
| LDH: | 283, 213 |
| LDL-cholestérol: | 335, 20-21 |
| L-Dopa: | 217, 448-453 |
| Lecture critique: | 262, 140-145 |
| Légionellose: | 277, 401; 281, 122-123 |
| Legg-Calvé-Perthès: | 229, 22-25 |
| Leiomyosarcome: | 293, 26-27 |
| Leishmaniose: | 291, 32-35 |
| Lentigo malin: | 324, 15-16 |
| Lentilles de contact: | 311, 23-25 |
| Leptospirose: | 347, 14-15 |
Lésion:
– abdominale:
– conjonctivale:
– érythémateuse:
– inflammatoire: | 293, 34
318, 18-19
263, 197
291, 32-35 |
| Leucocytose: | 294, 46 |
| Leucopénie: | 294, 48 |
| Lévothyroxine: | 331, 11-13 |
| Lèvres: | 342, 18-19 |
| Lichen striatus: | 200, 78-81; 337, 12-13 |
| Lichenification: | 284, 237 |
Ligament:
– croisé postérieur:
– latéral externe:
– latéral interne:
– scapho-lunaire:
– triangulaire du poignet: | 296, 48-55
214, 272-277
296, 48-55
296, 48-55
296, 48-55 |
Ligne:
– de Blaschko:
– de tension: | 337, 12-13
203, 208-212 |
| Linea nigra: | 345, 13-14 |
| Lipome: | 269, 19 |
Lithiase:
– rénale:
– salivaire:
– urinaire: | 313, 15-16
267, 369
292, 25 |
| Lithium: | 307, 8-10 |
| Lombalgie: | 217, 444-447; 226, 425; 245, 307-309; 264, 228-232;
277, 392-397; 293, 31; 293, 33-34; 305, 22-28;
306, 34-41; 311, 11-12; 312, 13-14; 312, 23-24;
313, 15-16; 317, 21-22; 326, 11-12; 332, 22-23 |
| Lupus: | 288, 439; 295, 34-43; 333, 11-13; 333, 17-18 |
Luxation:
– congénitale de la hanche:
– de la rotule:
– des tendons péroniers:
– gléno-humérale: | 308, 30-33
222, 164-173; 223, 220-228
224, 294-297
296, 48-55 |
| Lymphœdème: | 296, 8-18; 338, 17-19 |
| Lymphome non hodgkinien: | 250, 83; 344, 19-20 |
| (haut de la page) |
| Macrocytose: | 236, 384-391 |
| Macula: | 226, 388-392 |
| Maculopathie liée à l’âge: | 311, 23-25 |
Magistrales:
Acné rosacée:
Gale:
Hyperhydrose plantaire: | 220, 67
228, 533
244, 255 |
| Magnésémie: | 341, 19-22 |
| Maison de repos: | 218, 480-485; 245, 296-297; 306, 44-48; 322, 6-11 |
| Maison médicale: | 334, 17-18 |
| Mal aigu des montagnes: | 284, 244-253 |
| Mal de gorge: | 211, 145; 252, 144-149 |
| Mal des transports: | 338, 11-13 |
| Maladie à déclaration obligatoire: | 274, 266-267; 304, 48-52 |
| Maladie auto-immune: | 295, 34-43 |
| Maladie chronique: | 214, 302-304; 321, 19-20 |
| Maladie cœliaque: | 200, 60-64; 209, 41; 235, 332-339; 268, 429;
332, 22-23 |
| Maladie coronaire: | 345, 12 |
| Maladie de Basedow: | 294, 20-22; 341, 13-16; 342, 13 |
| Maladie de Crohn: | 308, 12-24; 324, 13-14; 348, 22-23 |
| Maladie de Horton: | 275, 304-306; 341, 23-24 |
| Maladie de Ledderhose: | 247, 395 |
| Maladie de Lyme: | 248, 453; 274, 255; 284, 228-233; 325, 10;
330, 20-22; 337, 14-15; 338, 11-13 |
| Maladie de Ménière: | 318, 06-15 |
| Maladie de Mordor: | 327, 18-19 |
| Maladie des griffes du chat: | 251, 127 |
| Maladie de Verneuil: | 306, 50-55; 341, 13-16 |
| Maladie de Waldenström: | 294, 8-14; 344, 19-20 |
| Maladie thrombo-embolique: | 237, 477; 265, 270-274 |
| Maladie infectieuse: | 298, 32-38 |
| Maladie inflammatoire intestinale: | 308, 12-24 |
| Maladie tropicale: | 344, 6-11 |
| Malaise vagal: | 252, 169 |
| Malaria: | 244, 267; 298, 26-29; 317, 23-24; 329, 17-19 |
| Malformation d’Arnold-Chiari: | 298, 52-54 |
| Malformation rénale: | 205, 347 |
| Mallet finger: | 260, 63 |
| Malnutrition: | 289, 44-47; 294, 45; 295, 54-60 |
| Malposition dentaire: | 338, 12-13 |
| Mammographie: | 306, 12-19 |
| Mammotest: | 218, 509; 219, 21; 221, 121; 222, 195; 224, 291;
226, 421-423; 254, 244-245; 308, 8-10 |
| Manie: | 282, 140-145 |
| MAPA (Mesure Ambulatoire de la Pression Artérielle): | 233, 224-228; 299, 26-32 |
Marqueurs:
– biologiques:
– osseux: | 205, 243-344
213, 236-238 |
| Mastalgie: | 269, 28-30 |
| Mastectomie: | 314, 15-16 |
| Mastocytose: | 304, 34-41 |
| Mastodynie: | 269, 28-30; 299, 34-39 |
| MDRD2: | 283, 200-203 |
| Médecin: | 238, 526-527; 306, 24-32; 336, 6-12 |
| Médecine de première ligne: | 330, 20-22 |
| Médecine du sport: | 213, 244-246; 214, 272-277; 224, 294-297; 228, 500-507;
240, 74-80; 269, 32-33; 271, 117; 292, 19 |
| Médecine du travail: | 302, 42-44; 329, 6-11 |
| Médecine générale: | 252, 154-156; 255, 289-291; 260, 70-73; 310, 13-14;
335, 12-14 |
| Médecine légale: | 273, 200-207 |
| Médecine préventive: | 202, 164-166; 266, 336-337; 266, 338-340 |
| Médecins vigies: | 219, 17-18; 287, 384-386 |
| Médicaments: | 231, 120-123; 297, 24-32; 303, 26-31; 309, 23-24;
318, 16-17 |
| Mégalérythème: | 233, 240-243; 348, 16-17 |
| Mélanome: – épidermique: | 202, 170-172; 297, 24-32; 300, 16-18; 318, 18-19;
323, 20-23; 334, 19-20; 338, 20-24
324, 15-16 |
| Mélanose de Dubreuilh: | 324, 15-16 |
| Mélatonine: | 344, 16-18 |
| Membrane d’Hassner: | 254, 243 |
| Mémoire: | 309, 17-22; 340, 16-17 |
| Ménarche: | 245, 284-291 |
| Méningisme: | 244, 267 |
| Méningite: | 278, 447; 298, 26-29; 338, 19-22 |
| Méningocoque: | 244, 246-247 |
| Ménisque: | 222, 164-173; 226, 417-419; 309, 11-12 |
| Ménopause: | 207, 424-428; 240, 64-69; 291, 26-27; 300, 26-34;
311, 11-12; 312, 13-14; 324, 6-9 |
| Ménorragie: | 294, 50 |
| Méralgie paresthésique: | 265, 295-296 |
| Mesh: | 297, 34-46 |
| Message: | 199, 38-39 |
| Métatarsiens: | 221, 112-120 |
| Metformine: | 327, 20-25 |
| Méthadone: | 204, 282-287; 267, 358-362 |
| Méthode PRC: | 200, 88-89 |
| Méthotrexate: | 271, 96-105; 296, 40-44; 328, 10-12; 332, 22-23 |
| Méthylphénidate: | 238, 496-500 |
| Métrorragie: | 206, 397 |
| MGUS: | 294, 8-14 |
| MICI: | 348, 22-23 |
| Microalbuminurie: | 288, 404-411 |
| Microchirurgie: | 201, 132-137 |
| Micro-ondes: | 270, 52-59 |
| Microparticules: | 317, 23-24 |
| Mictalgies: | 213, 253 |
| Migraine: | 285, 272-277; 303, 44-49; 307, 8-10; 313, 19-21;
322, 12-13; 324, 10-12; 326, 23-24; 332, 6-11 |
| Milieu rural: | 324, 19-20 |
| Mirtazapine: | 294, 17 |
| Mise en observation: | 278, 420-427; 331, 16-18; 343, 20 |
| Mise sous protection: | 343, 20 |
| Mobilophonie: | 270, 52-59 |
| Mode de vie: | 238, 504-505 |
| Modèles d’organisation des soins de santé: | 295, 22-30 |
| Molluscum contagiosum: | 260, 66-67; 329, 12-14 |
| Mono-arthrite: | 246, 353-357; 310, 15-16; 334, 11-12 |
| Mononucléose: | 211, 145; 248, 453; 290, 52-53 |
| Monoxyde de carbone: | 265, 284-288, 272, 166-170 |
| Morphine: | 279, 20-21; 290, 44-45; 320, 17 |
| Morpions: | 341, 13-16 |
Mort:
– naturelle/suspecte:
– subite: | 230, 64-67; 303, 44-49
225, 332-341 + addenda
248, 435; 290, 26-29; 316, 6-13; 324, 10-12 |
Mortalité:
– fœto-maternelle:
– périnatale: | 246, 332-341
329, 12-14 |
| Motivation: | 298, 40-42; 299, 40-42; 299, 44-47 |
| MRSA: | 218, 480-485; 322, 6-11 |
| MST: | 228, 518-521; 290, 48-51; 299, 34-39; 315, 21-24 |
| Mucolytique: | 307, 22-28 |
| Multimorbidité: | 325, 10; 336, 22-24; 340, 11-13 |
| Muscle soléaire accessoire: | 317, 17-18 |
| Musicien: | 238, 512-521 |
| Mutation BRCA2: | 314, 15-16 |
| Myasthénie: | 291, 38-44 |
| Mycobactérie: | 316, 16-17 |
| Mycoplasma pneumoniae: | 211, 145; 251, 111; 299, 50-52; 329, 20-21 |
| Mydriase: | 273, 211 |
| Myélome: | 294, 8-14 |
| Myocardite: | 302, 46-49 |
| Myopathie: | 290, 14-16; 322, 12-13 |
| Myopie: | 226, 388-392 |
| Myorelaxants: | 306, 34-41 |
| Mytilisme: | 335, 22-23 |
| (haut de la page) |
Nævus:
– bénin:
– bleu:
– de Becker:
– de Sutton:
– sébacé:
– spilus: | 340, 14-15
340, 14-15
306, 20-23
297, 22-23
258, 408-414; 302, 20-21
306, 20-23 |
| Nalméfène: | 313, 24-25; 314, 6-14 |
| Naltrexone: | 293, 47 |
| Narcolepsie: | 292, 54-55 |
| NASH: | 225, 356-360; 324, 17-18 |
| Nébuliseur humide: | 199, 8-12 |
| Nécrobiose lipoïdique: | 211, 128-131 |
| Négociation: | 212, 173-175 |
| Néoplasie intestinale: | 200, 91 |
Néphrite:
– interstitielle: | 281, 125
255, 303; 329, 17-19 |
| Néphropathie: | 213, 216-222 |
Nerf:
– facial:
– fémoro-cutané:
– optique:
– pudendal:
– radial: | 313, 17-18
265, 295-296
324, 10-12
264, 250-251
338, 17-18 |
| Neuroborréliose: | 285, 309 |
| Neurofibromatose: | 317, 21-22 |
| Neurofibrome: | 222, 201 |
| Neuro-imagerie: | 347, 18-19 |
| Neuroleptiques: | 229, 8-15; 242, 168-174; 317, 19-20; 343, 16-17 |
| Neuronite vestibulaire: | 318, 06-15 |
| Neuropathie: | 254, 248-255; 341, 13-16 |
| Neuropsychologie: | 340, 16-17 |
| Neutropénie: | 235, 365; 253, 202-209; 296, 40-44 |
Névralgie:
– d’Alcock:
– du trijumeau: | 201, 132-137
264, 250-251
313, 19-21 |
| Névrodermite: | 284, 237 |
| Nicotine: | 232, 178-180; 251, 112-115; 272, 152-154; 272, 162-165;
295, 16-21 |
| NNT: | 217, 455-457 |
Nodule:
– cutané:
– d’hyperplasie fibro-épithéliale:
– pulmonaire
– thyroïdien: | 247, 395
338, 12-13
201, 126-129; 235, 347-348; 236, 395-396; 275, 299
300, 40-46
220, 80-82 |
| Normes de soins: | 296, 8-18 |
| Norovirus: | 286, 316-321 |
| Notice: | 318, 16-17 |
| Nourrisson: | 228, 522-526; 323, 20-23 |
| Noyade: | 317, 15-16 |
| NT-pro-BNP: | 280, 78-79 |
| Nutrition: | 245, 296-297; 310, 20-22; 317, 15-16; 329, 12-14;
347, 14-15 |
| Nystagmus: | 233, 248-254 |
| (haut de la page) |
| Obésité: | 208, 468-473; 220, 60-66; 303, 44-49; 307, 12-19;
307, 30-45; 309, 23-24; 310, 20-22; 324, 17-18;
326, 15-17; 338, 17-19; 348, 20-21 |
| Observance: | 200, 82-84 |
| Occlusion intestinale: | 257, 391; 304, 42-47 |
Œdème:
– cérébral d’altitude:
– de Quincke:
– pulmonaire aigu:
– pulmonaire d’altitude: | 202, 191; 295, 54-60; 299, 34-39; 318, 26-27
284, 244-253
230, 93
316, 18-19
284, 244-253 |
| Œil: | 228, 528-530 |
| Œsophage de Barrett: | 263, 201-205; 291, 18 |
Œsophagite:
– de reflux: | 222, 184-186; 343, 23-24
212, 197 |
| Œstrogènothérapie substitutive: | 291, 27-28 |
| Œstroprogestatifs: | 207, 424-428 |
| Omarthrose: | 303, 26-31 |
| Omoplate: | 269, 32-33 |
| Oncologie: | 236, 418-419 |
| Ondansétron: | 293, 47-48 |
| Ongle: | 295, 32-33; 300, 22-24; 343, 18-19 |
| Onychodystrophie: | 310, 15-16; 343, 18-19 |
| Onychomycose: | 300, 22-24; 314, 15-16; 338, 20-24; 344, 14-15 |
| Ophtalmologie: | 311, 23-25 |
| Opioïdes: | 290, 32-41; 294, 18 |
| Orchidopexie: | 247, 380-385 |
| Oreillons: | 293, 54-57; 304, 48-52 |
| Orf: | 201, 126-129; 275, 299; 321, 13-14 |
Organisation:
– de la pratique:
– des soins: | 299, 18-20; 323, 20-23; 340, 11-13; 344, 22-23
307, 22-28; 311, 11-12; 312, 13-14; 321, 19-20;
334, 17-18; 335, 12-14; 336, 22-24; 346, 15 |
| Orgasme féminin: | 211, 142-143 |
| Orgelet: | 311, 23-25 |
| Orthostatisme: | 211, 134-140 |
| Oseltamivir: | 267, 366-367 |
| Ostéochondrite: | 239, 8-15 |
| Ostéonécrose: | 324, 19-20 |
| Ostéoporose: | 213, 236-238; 214, 292-294; 286, 326-329; 293, 24;
298, 44-50; 300, 26-34; 303, 8-17; 303, 44-49;
304, 8-24; 324, 19-20; 327, 16-17; 340, 11-13 |
Otite:
– externe:
– moyenne:
– moyenne aiguë: | 318, 16-17; 337, 11
331, 11-13
202, 178-180 |
| Otorrhée: | 209, 8-12 |
| Oubli: | 213, 226-227; 319, 20-21 |
| Outils de communication: | 243, 202-203 |
| Ovarite: | 219, 41 |
| Ovidés: | 201, 126-129 |
Oxygénothérapie:
– hyperbare: | 291, 23-24
303, 26-31 |
| Oxymétrie: | 249, 24-28 |
| (haut de la page) |
| Pacemaker: | 325, 20-21; 336, 17-18 |
| Palpitations: | 199, 41; 212, 178-181; 265, 281 |
| Paludisme: | 298, 26-29 |
| Panaris: | 314, 17-18 |
| Pandémie: | 267, 366-367 |
| Panniculite a frigore: | 298, 24-25 |
| Pansements hydrocolloïdaux: | 294, 25; 295, 54-60 |
| Papillomavirus: | voir HPV |
Papules:
– blanches:
– perlées péniennes:
– piézogéniques: | 336, 15-16
333, 19-20
329, 15-16
335, 15-16 |
| Papulose lymphomatoïde: | 236, 395-396 |
| Paracétamol: | 304, 26-28; 326, 11-12 |
| Paralysie faciale: | 285, 309; 290, 52-53 |
| Paranoïa: | 264, 241 |
| Paraphénylènediamine (PPD): | 253, 199 |
| Parapoxvirus: | 321, 13-14 |
| Paraprotéinémie: | 294, 8-14; 344, 19-20 |
| Parasomnie: | 241, 108-113 |
| Paresthésies: | 267, 385 |
| Parkinson: | 217, 448-453; 224, 313; 242, 179; 329, 12-14 |
| Parotide: | 256, 329 |
| Parotidite: | 293, 54-57; 304, 48-52 |
| Partage des données: | 206, 390-393 |
| Parvovirus: | 233, 240-243; 348, 16-17 |
Pathologie:
– cardiovasculaire:
– iatrogène: | 227, 454-456
329, 17-19 |
| Patient borderline: | 207, 416-420 |
| Pauvreté: | 305, 46-49; 334, 13-15 |
| PCSK9: | 335, 20-21 |
| Pédagogie: | 316, 14-15 |
| Pédiatrie: | 208, 484-485; 301, 24-28; 307, 22-28; 329, 12-14 |
| Pédiculose: | 341, 13-16 |
| Pelade: | 219, 35-38; 222, 180-183 |
| Pemphigus: | 322, 14-15 |
| Pénicilline: | 234, 302-309 |
| Peptide B natriurétique: | 224, 282-285 |
Perforation:
– du globe oculaire:
– utérine: | 203, 229-235
345, 22-24 |
| Péricardite: | 261, 107; 302, 46-49 |
| Périménoppause: | 291, 24-25 |
| Périnéologie: | 219, 28-34 |
| Périonyx: | 202, 174-177 |
| Périonyxis: | 314, 17-18 |
| Péritrochantérite: | 243, 196-199 |
| Permanence des soins: | 297, 24-32 |
| Péroné: | 221, 112-120 |
| Personnalité borderline: | 280, 68-71; 305, 22-28; 318, 20-22; 321, 21 |
| Personne âgée: | 281, 96-103; 286, 326-329; 289, 34-41; 309, 6-10;
317, 19-20; 318, 20-22; 319, 20-21; 322, 6-11;
322, 12-13; 328, 6-9 |
Perte:
– de conscience:
– de vision: | 240, 91
311, 23-25 |
| Perte de poids: | 268, 429 |
| Perturbateurs endocriniens: | 348, 20-21 |
| Pervers narcissique: | 202, 156-160 |
| Perversion morale: | 202, 156-160 |
| Pharmacovigilance: | 255, 276-281; 297, 24-32; 298, 44-50; 302, 32-40;
338, 19-22 |
| Pharyngite: | 252, 144-149 |
| Pharynx: | 210, 66-67 |
| Phlébite: | 293, 24 |
Photothérapie:
– dynamique: | 236, 406-412
289, 8-19 |
| Phtalates: | 348, 20-21 |
| Phyto-œstrogènes | 311, 11-12; 312, 13-14 |
| Phytostérols: | 297, 24-32 |
| Phytothérapie: | 247, 388-393 |
Pied:
– d’athlète:
– diabétique:
– plat, creux: | 328, 13-14
250, 67
213, 216-222
248, 420-427; 322, 19-21 |
| Pigmentation bénigne anormale: | 345, 13-14 |
| Pinguécula: | 292, 20-21 |
| Piscine: | 274, 244-251 |
| Placebo: | 290, 14-16; 347, 18-19 |
| Plaie: | 203, 208-212; 295, 54-60; 303, 18-20; 307, 22-28;
312, 15-16 |
| Plaisir sexuel: | 211, 142-143 |
| Plan de soins: | 336, 22-24 |
| Planning familial: | 269, 08-12 |
| Plaquettes: | 306, 8-10; 317, 23-24 |
| Pleurs: | 290, 14-16 |
| Plexus brachial: | 222, 201 |
| Plombémie: | 211, 122-123 |
| Pneumocoque: | 244, 246-247; 298, 26-29; 310, 23-25; 341, 13-16 |
| Pneumologie: | 301, 24-28 |
| Pneumonie: | 234, 313; 249, 35; 298, 26-29; 300, 40-46;
310, 23-25; 313, 15-16; 341, 13-16; 347, 14-15 |
Pneumopathie:
– infectieuse: | 300, 40-46; 329, 20-21; 332, 17-21
301, 24-28 |
| Pneumothorax: | 297, 8-16 |
Poids:
– corporel:
– de naissance: | 289, 20-23
246, 332-341 |
| Politique de santé: | 314, 23-24 |
Pollution:
– intérieure: | 211, 122-123; 333, 11-13
318, 20-22 |
| Polyarthralgies: | 328, 22-23 |
| Polyarthrite rhumatoïde: | 271, 96-105; 295, 34-43; 298, 44-50; 313, 15-16;
332, 22-23; 333, 11-13; 333, 17-18 |
| Polyconsommation: | 348, 18-19 |
| Polymastie: | 288, 415 |
| Polymédication: | 200, 82-84; 294, 24; 336, 22-24 |
| Polymyalgie rhumatismale (PMR): | 333, 17-18 |
| Polynévrite: | 314, 25-26 |
| Polypose colique: | 260, 52-59 |
| Polythélie: | 288, 415 |
Ponction:
– articulaire: | 204, 291
202, 188-189; 259, 26-29 |
| Porphyrie: | 328, 22-23 |
| Posologie: | 335, 6-11 |
| Pouce: | 296, 48-55 |
| Poussée tentionnelle: | 223, 257 |
| Poux: | 341, 13-16 |
| Poxvirus: | 275, 299 |
| Pratique professionnelle: | 297, 24-32 |
| Préalbumine: | 294, 45 |
| Précarité: | 278, 432-433; 312, 15-16; 324, 13-14; 331, 19-20;
334, 13-15 |
| Prégabaline: | 346, 15 |
Prélèvement:
– sanguin:
– post-mortem | 256, 320-325; 294, 44-45
273, 200-207 |
| Prématurité: | 246, 332-341 |
| Prémédication: | 210, 66-67 |
Prescription:
– appropriée:
– électronique:
– inappropriée: | 318, 16-17; 334, 17-18; 336, 22-24
319, 20-21
317, 23-24
305, 30-38; 328, 6-9 |
Pression:
– artérielle:
– veineuse: | 279, 25-30; 288, 427-431
303, 26-31 |
| Prévention: – cardiovasculaire: – primaire:
– quaternaire:
– secondaire: | 207, 436-445; 212, 164-169; 215, 336-337; 242, 163-165;
251, 122-123; 297, 24-32; 298, 32-38; 308, 40-51;
309, 6-10; 313, 15-16; 313, 22-23; 314, 23-24;
317, 15-16; 344, 22-23; 346, 15
248, 448-449; 275, 288-295; 281, 96-103;
302, 16-18; 348, 15
301, 8-15; 315, 21-24; 333, 11-13
342, 20-22
233, 244-246; 340, 18 |
| Prise de poids: | 289, 20-23 |
| Probiotiques: | 253, 188-195 |
| Professionnalisme: | 306, 24-32 |
| Projet thérapeutique: | 338, 19-22; 340, 11-13; 340, 18 |
| Prolapsus rectal: | 257, 373 |
| Promotion de la santé: | 242, 163-165; 255, 289-291; 278, 432-433; 325, 15-19 |
| Propythiouracile: | 304, 30-31 |
| Prostate: | 293, 23 |
| Prostatite: | 292, 23-24 |
| Protéinurie: | 288, 404-411; 292, 28-29; 301, 36-44; 343, 6-15 |
Prothèse:
– d’épaule
– de genou:
– de hanche:
– discale: | 303, 26-31
241, 118-120
268, 416-425
267, 378-383 |
| Prurit: – anal: | 200, 78-81; 213, 253; 215, 340-343; 227, 481;
246, 349; 278, 431; 284, 237; 304, 34-41;
319, 26-27; 333, 21-22
341, 17-18 |
| PSA: | 292, 29-30; 293, 22; 296, 40-44; 315, 16-20;
321, 19-20 |
| Pseudo-polyarthrite rhizomélique | 270, 79; 275, 304-306 |
| Pseudo-sciatalgie: | 274, 271 |
| Psoriasis: – en gouttes: | 217, 438-440; 243, 209; 287, 371; 334, 11-12;
338, 20-24
338, 14-15 |
| Psychiatrie: | 323, 20-23 |
| Psychogériatrie: | 344, 16-18 |
| Psychose: | 264, 241 |
| Psychosomatique: | 214, 311 |
| Psychothérapie: | 207, 416-420; 219, 8-13; 309, 11-12; 316, 20-22;
347, 18-19 |
| Psychotropes: | 344, 16-18 |
| Ptérygion: | 292, 20-21; 325, 11-12 |
| Ptosis de la paupière: | 299, 22-24 |
| Puberté (tardive, précoce): | 245, 284-291; 337, 19-20 |
| Publication médicale: | 291, 19 |
| Pulsions: | 226, 398-399 |
Purpura:
– d’Henoch-Schönlein: | 218, 511; 304, 30-31
323, 14-15; 336, 19-21 |
| Pustulose faciale: | 331, 14-15 |
| Pyélonéphrite: | 205, 347; 226, 425; 243, 223; 253, 215; 292, 23-24 |
| Pyrosis: | 332, 12-14 |
| Pytiriasis capitis: | 219, 35-38 |
| (haut de la page) |
| QT long: | 319, 6-15 |
| Qualité des soins: | 224, 276-279; 260, 70-73; 281, 108-109; 289, 20-23;
295, 22-30; 314, 21-22; 321, 19-20; 323, 20-23;
328, 10-12; 331, 11-13; 333, 11-13 |
| Qualité de vie: | 245, 296-297; 305, 46-49 |
| Questionnaire DN4: | 247, 400-405 |
| Queue de cheval: | 217, 459 |
| Quinolone: | 239, 43 |
| |
| RAA: | 252, 144-149 |
| Radioactivité: | 296, 20-37 |
| Radiofréquences: | 270, 52-59 |
Radiographie:
– du thorax: | 305, 22-28
300, 40-46 |
| Radiologie: | 319, 22-23 |
| Radiothérapie: | 315, 12-13 |
| Rage: | 298, 26-29 |
| Raisonnement clinique: | 338, 6-11 |
| Rapport de vraisemblance positif: | 329, 17-19 |
Rayonnements:
– ionisants: | 293, 29
296, 20-37; 323, 6-11 |
| Réanimation cardio-pulmonaire: | 221, 132-139 |
| Récepteurs GABA-B: | 293, 47-49 |
Recherche:
– documentaire:
– qualitative: | 297, 34-46; 301, 8-15
280, 52-56; 292, 38-47 |
| Récolte de données: | 235, 343-344; 240, 84-89; 254, 232-237 |
| Recommandations de bonne pratique: | 200, 70-72; 202, 178-180; 204, 260-264; 212, 184-186;
250, 78-80; 256, 332-337; 272, 152-154; 272, 156-159;
277, 392-397; 279, 8-15; 279, 25-30; 297, 18-20;
297, 24-32; 306, 24-32; 323, 16-17; 348, 20-21 |
| Récompense: | 299, 44-47 |
Rectocolite:
– ulcéro-hémorragique: | 304, 26-28; 308, 12-24
324, 13-14; 348, 22-23 |
| Rectorragie: | 348, 22-23 |
| Rectosigmoïdoscopie: | 299, 18-20 |
| Réduction de la consommation (d’alcool): | 313, 24-25; 314, 6-14 |
| Réflexion sur l’évolution de la MG: | 252, 154-156 |
| Reflux gastro-œsophagien: | 222, 184-186; 263, 201-205; 308, 30-33; 309, 14-16;
318, 16-17; 332, 12-14 |
| Régime: | 310, 20-22 |
| Réhabilitation cognitive: | 348, 18-19 |
| Rein: | 301, 30-35 |
| Relation médecin/patient: | 226, 398-399; 234, 293-294; 238, 526-527; 291, 56-58;
297, 18-20; 300, 36-38; 305, 46-49; 307, 46-48;
308, 8-10; 309, 25-26; 315, 21-24; 330, 20-22;
331, 19-20; 334, 13-15; 334, 17-18; 344, 22-23 |
| Remboursement: | 239, 30-35; 256, 332-337 |
| Remplacement valvulaire cardiaque: | 296, 40-44 |
| Renforcement excentrique: | 240, 74-80 |
Repérage:
– précoce: | 323, 16-17
314, 23-24 |
| Repli conjonctival: | 340, 19-20 |
| Représentation de la maladie: | 208, 476-479 |
| Réseau: | 310, 20-22 |
| Résilience: | 219, 8-13 |
| Responsabilité sociale: | 335, 17-19 |
| Resurfaçage: | 335, 20-21 |
| Retraite: | 344, 22-23 |
| Rhinite: | 338, 14-16 |
Rhumatisme:
– inflammatoire des ceintures:
– psoriasique: | 298, 44-50
310, 15-16 |
| Rhumatologie: | 231, 124-127; 333, 11-13 |
| Rhume de hanche: | 308, 30-33 |
| Rickettsia: | 292, 32-34 |
Risque:
– absolu / relatif:
– cardiovasculaire:- chirurgical:
– nucléaire:
– psychosocial: | 217, 455-457
212, 164-169; 233, 244-246; 236, 395-396; 237, 451-452;
238, 504-505; 240, 64-69; 243, 202-203; 248, 448-449;
256, 332-337; 287, 360-366; 298, 20-23; 322, 22-24;
335, 12-14; 338, 11-13; 340, 18
338, 11-13
296, 20-37
329, 6-11 |
| Rituximab: | 250, 83 |
| RMN: | 309, 11-12 |
| Ronflement: | 257, 376-383 |
| Rosacée: | 309, 14-16; 332, 12-14 |
| Rotation: | 190, 76-81 |
| Rotavirus: | 235, 361-363; 244, 246-247; 300, 16-18 |
| Rotule: | 226, 417-419; 331, 11-13 |
| Rougeole: | 288, 434-437 |
| Rubéole: | 241, 117 |
| Rupture d’anévrysme: | 301, 16-18 |
| Rupture tendineuse: | 279, 19 |
| (haut de la page) |
| Salpingite: | 290, 48-51 |
Santé:
– du médecin:
– environnementale:
– mentale:
– publique:
– subjective: | 316, 14-15
318, 20-22
251, 122-123
215, 346-352; 314, 15-16; 323, 20-23
235, 350-355; 298, 32-38; 334, 13-15
310, 17-19 |
| Sarcoïdose: | 210, 76-79; 327, 26-27; 346, 23-24 |
| Sarcome de Kaposi: | 328, 15-16 |
| Sarcopénie: | 289, 34-41; 295, 54-60 |
| Satisfaction (en pratique de MG): | 266, 314-317; 310, 13-14 |
| Saturomètre: | 249, 24-28 |
Scanner:
– thoracique: | 313, 19-21
335, 20-21 |
| Scaphoïde tarsien: | 271, 117 |
| Scapula alata: | 269, 32-33 |
| Schizophrénie: | 325, 13-14 |
| Sciatalgie: | 201, 139; 266, 341; 289, 48-49; 295, 64-66;
309, 11-12; 340, 11-13; 346, 15 |
| Sclérodermie: | 333, 11-13 |
| Sclérose en plaques: | 303, 52-55; 313, 19-21 |
| Sclérothérapie: | 230, 86-91 |
| Scoliose: | 322, 19-21 |
| SCORAD: | 232, 168-174 |
| Scorbut: | 289, 44-47; 296, 8-18 |
| Score ABCDE: | 316, 18-19 |
| SDF: | 289, 44-47; 296, 8-18 |
| Sécheresse buccale: | 324, 10-12 |
| Secrétariat: | 323, 20-23 |
| Secret médical: | 204, 268-272; 206, 390-393 |
Sécurité:
– alimentaire: | 210, 60-60
286, 316-321 |
| Sédation: | 304, 42-47 |
| Sédentarité: | 291, 16 |
| Séjour illégal: | 311, 15-19 |
| Semelles: | 248, 420-427 |
| Sensibilité: | 329, 17-19 |
| Septicémie: | 240, 91; 243, 223 |
| Sérologie: | 335, 12-14 |
| Sertraline: | 294, 17 |
| Service d’urgence: | 258, 408-414; 311, 11-12; 312, 13-14 |
Sevrage:
– alcoolique:
– tabagique: | 279, 37
313, 24-25
250, 78-80; 251, 112-115; 252, 157-158; 265, 284-288;
265, 289-290; 272, 140-141; 272, 150-151; 272, 156-159;
272, 162-165; 272, 166-170; 272, 172-179; 272, 183;
278, 436-439; 278, 444-446; 287, 372-377; 292, 18;
295, 16-21; 296, 8-18; 297, 18-20; 299, 44-47;
314, 15-16; 315, 21-24; 323, 20-23; 325, 13-14;
333, 6-10 |
| Sexualité: | 271, 120-121; 344, 22-23 |
| SGLT-2 inhibiteurs: | 327, 20-25 |
| SIDA: | 250, 56-61; 252, 159; 315, 21-24 |
| Sidéropénie: | 324, 19-20 |
| Signes vitaux: | 300, 16-18 |
| Sinus carotidien: | 210, 93 |
Sinusite:
– aigüe:
– ethmoïdale: | 228, 535; 319, 16-17
307, 8-10
294, 40-43; 332, 24-25 |
| Sitagliptine: | 266, 328-333 |
| Socio-anthropologie: | 322, 16-18 |
| Sodium oxybate: | 348, 18-19 |
| Soins de santé primaires: | 235, 343-344; 258, 408-414; 295, 22-30; 297, 34-46;
301, 8-15; 334, 17-18 |
| Soins palliatifs: | 285, 282-285; 298, 20-23; 301, 24-28; 304, 42-47;
322, 12-13; 336, 22-24 |
| Somatisation: | 233, 259-261; 268, 402-406 |
| Sommeil: | 244, 240-243; 257, 376-383; 324, 10-12; 327, 6-15 |
| Somnifères: | 344, 12-13; 344, 16-18 |
| Somnolence: | 292, 54-55 |
| Souffrance au travail: | 305, 22-28 |
| Sourcil: | 222, 180-183 |
| Spasticité: | 282, 152-157 |
| Spécificité: | 329, 17-19 |
| Spirométrie: | 216, 390-393; 272, 160-161; 298, 8-18; 299, 26-32 |
| Spironolactone: | 314, 15-16 |
| Splénectomie: | 215, 336-337; 294, 45-46 |
| SpO2: | 249, 24-28 |
| Spondylarthrite ankylosante: | 332, 22-23; 333, 11-13 |
| Spondylodiscite: | 226, 425 |
| Spondylolisthésis: | 315, 14-15 |
| Spondylolyse: | 217, 444-447; 315, 14-15 |
| Sport: | 216, 386-387; 316, 6-13 |
| SSRI: | 304, 26-28 |
| Stadification: | 321, 15-16 |
| Statines: | 239, 30-35; 256, 332-337; 281, 96-103; 290, 14-16;
303, 44-49; 310, 13-14; 311, 11-12; 312, 13-14;
315, 21-24; 321, 11-12; 322, 12-13; 322, 22-24;
335, 20-21 |
| Statistique: | 329, 17-19 |
| Statut du médecin: | 344, 22-23 |
| Stéatose hépatique: | 225, 356-360; 324, 17-18 |
Sténose:
– aortique:
– artérielle:
– carotidienne: | 277, 376-378; 296, 40-44
217, 459
291, 17 |
| Stérilité: | 248, 438-445; 290, 48-51; 320, 6-16 |
| Stopp&start: | 305, 30-38; 319, 20-21; 328, 6-9 |
Streptocoque:
– β-hémolytique: | 252, 144-149; 256, 347; 335, 12-14
346, 23-24 |
Stress:
– post-traumatique: | 319, 26-27
237, 475-476 |
| Stroke unit: | 212, 184-186 |
| Stupéfiant: | 344, 12-13 |
| Substituts nicotiniques: | 297, 18-20; 323, 20-23 |
| Suicide: | 287, 384-386; 300, 8-15; 302, 24-31; 307, 8-10;
309, 11-12; 319, 16-17; 326, 11-12; 327, 16-17;
328, 10-12; 331, 11-13; 331, 16-18 |
| Suivi thérapeutique: | 315, 21-24; 315, 21-24 |
| Sulfamides hypoglycémiants: | 327, 20-25 |
| Surdiagnostic: | 298, 20-23; 308, 8-10; 315, 16-20; 330, 20-22 |
Surdité:
– brusque: | 209, 8-12; 231, 112-117; 231, 128-131
330, 6-15 |
| Surmédicalisation: | 342, 20-22 |
| Surmenage: | 251, 122-123; 306, 24-32 |
| Suture: | 203, 208-212 |
Symptômes:
– inexpliqués:
– vasomoteurs: | 268, 402-406; 278, 449
324, 6-9 |
| Syncope: | 210, 93; 211, 134-140; 223, 236-239; 252, 169;
254, 257 |
| Syndrome canalaire: | 264, 250-251; 265, 295-296 |
| Syndrome carcinoïde: | 238, 528-529 |
| Syndrome coronarien: | 233, 244-246 |
| Syndrome d’alcoolisation fœtale: | 302, 24-31; 323, 12-13; 334, 21-22 |
| Syndrome d’apnée obstructive du sommeil: | 326, 6-10; 338, 11-13 |
| Syndrome de Brugada: | 290, 26-29 |
| Syndrome de Claude-Bernard-Horner: | 299, 22-24 |
| Syndrome de détresse respiratoire: | 301, 24-28 |
| Syndrome de Down: | 207, 436-445 |
| Syndrome de Guillain-Barré: | 314, 25-26; 338, 11-13 |
| Syndrome de la charnière dorsolombaire: | 316, 26-27 |
| Syndrome de l’intestin irritable: | 326, 11-12; 327, 16-17 |
| Syndrome de Morton: | 328, 13-14 |
| Syndrome de Poland: | 301, 20-21 |
| Syndrome de retard de phase du sommeil: | 294, 18 |
| Syndrome de sécrétion inappropriée d’ADH: | 301, 24-28 |
| Syndrome de Stevens-Johnson: | 251, 111 |
| Syndrome de stress post-traumatique: | 330, 16-17 |
| Syndrome de Südeck: | 208, 486-489 |
| Syndrome de Wallenberg: | 318, 06-15 |
| Syndrome d’Ulysse: | 330, 20-22 |
| Syndrome du messager: | 239, 19 |
| Syndrome dysentérique: | 237, 460-463 |
| Syndrome fémoropatellaire: | 331, 11-13 |
| Syndrome gériatrique: | 299, 26-32; 340, 11-13 |
| Syndrome grippal: | 281, 116-119; 299, 50-52; 315, 25-26; 347, 14-15 |
| Syndrome méningé | 276, 361 |
| Syndrome métabolique: | 242, 168-174; 324, 17-18 |
| Syndrome mixte: | 272, 160-161 |
| Syndrome néphrotique: | 318, 26-27 |
| Syndrome obstructif: | 249, 21 |
| Syndrome oral: | 338, 14-16 |
| Syndrome paranéoplasique: | 275, 317; 321, 6-10 |
| Syndrome parkinsonien: | 254, 248-255 |
| Syndrome restrictif: | 249, 21 |
| Syndrome sérotoninergique: | 304, 34-41 |
| Syphilis: | 286, 343-345; 315, 21-24 |
| Syringome: | 333, 19-20 |
| Système cardiovasculaire: | 295, 16-21 |
| Système de santé: | 324, 10-12; 336, 6-12 |
| Système rénine-angiotensine: | 345, 12 |
| (haut de la page) |
| Tabagisme: | 208, 490-495; 216, 390-393; 232, 178-180; 246, 344-346;
250, 78-80; 251, 112-115; 252, 157-158; 263, 184-188;
265, 284-288; 265, 289-290; 269, 24-27; 272, 140-141;
272, 145-146; 272, 147-148; 272, 150-151; 272, 152-154;
272, 156-159; 272, 162-165; 272, 166-170; 272, 172-179;
272, 183; 278, 444-446; 285, 288-289; 287, 372-377;
289, 27-32; 295, 16-21; 296, 8-18; 299, 44-47;
304, 26-28; 308, 8-10; 314, 15-16; 315, 21-24;
321, 22-23; 324, 13-14; 325, 13-14; 329, 12-14;
334, 21-22; 338, 11-13 |
| Tachycardie: | 199, 26-29; 223, 236-239; 229, 41 |
| Tænia saginata: | 216, 411 |
| Tako-Tsubo: | 331, 23-24 |
| Talalgie: | 328, 13-14 |
| Tamsulosine: | 310, 13-14 |
| Taping: | 312, 23-24 |
| TDAH: | 238, 496-500; 306, 24-32 |
| Télangiectasies nævoïdes: | 231, 124-127 |
| Téléphone: | 214, 280-281; 317, 15-16 |
| Tendinite: | 210, 80-85; 305, 14-16; 335, 20-21 |
Tendinopathie :
– médicamenteuse: | 346, 6-14
333, 17-18; 335, 12-14 |
| Tendon d’Achille: | 279, 19; 305, 14-16 |
| Tendon extenseur: | 260, 63 |
| Tennis elbow: | 240, 74-80 |
| Tentative de suicide: | 287, 384-386; 300, 8-15; 326, 11-12; 327, 16-17;
328, 10-12 |
| Tératogénicité: | 234, 276-284 |
Test:
– au monofilament:
– cutané:
– diagnostique:
– Elisa: | 213, 216-222
234, 302-309
315, 21-24
200, 88-89 |
| Testicule « yo-yo » | 247, 380-385 |
| Tests hépatiques (altération des -): | 324, 21-22 |
| Tétanos: | 206, 372-374; 220, 70-73 |
| Tétée: | 228, 522-526 |
| Tétraparésie: | 314, 25-26 |
| Thalassémie: | 294, 16 |
| Thélarche: | 245, 284-291 |
| Thérapie cognitivocomportementale: | 330, 16-17 |
| Thermomètre: | 216, 406-408 |
| Trichoépithéliome: | 336, 15-16 |
| Thrombocytose: | 294, 45-46 |
| Thrombo-embolie: | 246, 363; 295, 34-43; 299, 18-20 |
| Thrombopénie: | 281, 125; 294, 46; 317, 23-24 |
| Thrombophilie: | 265, 270-274; 295, 34-43; 345, 12 |
Thrombophlébite:
– superficielle: | 274, 271; 297, 24-32; 299, 34-39
327, 18-19 |
Thrombose:
– artérielle:
– coronarienne:
– veineuse: | 345, 12
325, 13-14
299, 34-39
201, 122-124; 293, 24; 306, 8-10; 325, 13-14;
334, 10 |
| THS: | 240, 64-69 |
| Thymorégulateurs: | 282, 140-145 |
| Thyroïdite: | 340, 19-20 |
| Thyrotoxicose: | 341, 13-16 |
| Tibia: | 221, 112-120 |
| Tinea corporis: | 282, 149 |
| Tique: | 274, 255; 284, 228-233; 308, 34-38 |
| TMS: | 283, 186-191 |
| Tophus goutteux: | 326, 13-14 |
| Torsades de pointes: | 319, 6-15 |
Torsion:
– ovarienne:
– testiculaire: | 305, 22-28
241, 135; 305, 22-28; 313, 6-14 |
| TOT: | 219, 28-34 |
| Toux: – chronique | 208, 484-485; 212, 197; 218, 498-505; 227, 481;
300, 40-46; 333, 23-24
323, 12-13; 337, 21-23 |
Toxicité:
– des médicaments: | 211, 122-123; 344, 12-13
301, 36-44 |
| Toxicomanie: | 216, 396-403; 267, 358-362; 279, 20-21; 338, 17-18 |
| Toxidermie médicamenteuse: | 331, 6-10; 338, 14-15 |
| Toxine botulinique: | 282, 152-157 |
| Toxoplasmose: | 246, 344-346; 276, 361 |
Traitement:
– hormonal substitutif:
– non médicamenteux: | 200, 82-84
207, 424-428
297, 24-32 |
| Tramadol: | 296, 58-61 |
| Tranquillisant: | 317, 19-20 |
| Transferrine: | 294, 49 |
Traumatisme:
– crânien:
– facial:
– osseux: | 239, 8-15; 296, 8-18
313, 19-21; 322, 19-21
240, 73
311, 11-12; 312, 13-14 |
| Tremblements: | 217, 448-453 |
| Trijumeau: | 201, 132-137 |
| Trisomie 21: | 207, 436-445 |
| Trochantérite: | 208, 501 |
| Troponine: | 285, 300-301 |
| Troubles alimentaires: | 310, 20-22 |
| Troubles anxio-dépressifs: | 269, 24-27 |
| Troubles bipolaires: | 282, 140-145; 323, 16-17; 344, 12-13 |
| Troubles cognitifs: | 323, 12-13; 323, 16-17; 324, 10-12; 340, 16-17 |
| Troubles de l’attachement: | 206, 364-368 |
| Troubles de la marche: | 254, 248-255; 298, 52-54 |
| Troubles de la personnalité: | 207, 416-420; 321, 21 |
| Troubles d’équilibre: | 221, 145; 254, 248-255 |
| Troubles de rotation: | 248, 420-427 |
| Troubles du comportement: | 317, 6-14; 317, 19-20; 343, 16-17; 344, 16-18 |
| Troubles du rythme: | 325, 20-21 |
| Troubles du rythme circadien: | 294, 18 |
| Troubles du sommeil: | 212, 197; 304, 34-41; 319, 20-21; 321, 11-12 |
| Troubles ioniques: | 239, 43; 243, 212-217 |
| Troubles moteurs: | 329, 12-14 |
| Troubles musculosquelettiques: | 238, 512-521 |
| Troubles neuropsychologiques: | 324, 10-12 |
| Trouble obsessionnel compulsif: | 295, 32-33 |
| Troubles phosphocalciques: | 301, 36-44 |
| TSH: | 292, 8-14 |
| Tuberculose: | 252, 159 |
| Tularémie: | 215, 357 |
Tuméfaction:
– pédiculée: | 256, 329; 317, 17-18
269, 19 |
Tumeur:
– bronchique bénigne:
– cervicale:
– médullaire: | 330, 23-24
249, 8-13
317, 21-22 |
| TVT: | 219, 28-34 |
| (haut de la page) |
Ulcère:
– chronique:
– de la cornée:
– gastrique: | 307, 22-28
291, 20-21
203, 229-235
229, 41; 332, 22-23 |
| Uméclidinium: | 337, 11 |
| Urétrite: | 292, 23-24 |
Urgence:
– psychiatrique: | 307, 22-28; 313, 6-14; 316, 18-19
316, 18-19; 331, 16-18 |
| Urologie: | 305, 8-12; 313, 6-14 |
| Urticaire: – chronique: | 223, 233-235; 258, 435; 304, 34-41; 319, 26-27;
331, 6-10
333, 21-22; 338, 20-24 |
| Usagers de drogues: | 204, 282-287; 258, 408-414 |
| |
| Vaccination: – anti-diphtérie/tétanos
– anti-diphtérie/tétanos/coqueluche
– anti-grippe H1N1:
– anti-HPV:
– anti-influenza:
– anti-méningococcique:
– anti-papillomavirus:
– anti-pneumococcique: – anti-rotavirus:
– anti-rougeoleuse:
– anti-RRO:
– anti-varicelleux:
– BCG:
– du voyageur: | 244, 246-247; 271, 112-114; 298, 20-23; 301, 24-28;
322, 12-13; 333, 17-18; 344, 12-13; 344, 22-23;
345, 18-19; 346, 15; 346, 18-21; 347, 14-15
348, 15
206, 372-374
220, 70-73; 266, 321-323
332, 12-14
245, 294-295; 250, 64-65; 288, 432-433
205, 320-321; 325, 6-9; 345, 15-16
291, 28
338, 11-13; 345, 20-21
205, 320-321; 288, 432-433; 291, 28; 300, 40-46;
310, 23-25; 323, 20-23; 341, 13-16
235, 361-363; 300, 16-18
288, 434-437
300, 16-18
291, 28; 337, 16-18
345, 12
298, 26-29; 329, 17-19 |
| Vaginite: | 208, 497-499 |
| Valgum: | 248, 420-427 |
| Valproate: | 323, 16-17 |
| Valvuloplastie percutanée: | 277, 376-378 |
| Vapoteur: | 333, 6-10 |
| Varénicline: | 250, 78-80; 272, 156-159; 328, 10-12 |
| Varice: | 303, 26-31 |
| Varicelle: | 234, 313; 238, 506-509 |
| Varicocèle: | 230, 86-91 |
| Varum: | 248, 420-427 |
| Vascularite: | 336, 19-21 |
| Vécu du patient: | 248, 430-432 |
| Vergetures: | 305, 14-16 |
| Verrue: | 299, 8-17; 334, 19-20 |
| Vertiges: | 221, 145; 223, 257; 233, 248-254; 236, 421; 303, 52-55;
318, 06-15 |
| Vésicule | 320, 18-19 |
| Viande rouge: | 313, 22-23 |
| Vie privée: | 204, 268-272 |
Vieillissement:
– de la peau: | 220, 85-89; 225, 344-345
289, 8-19 |
Violence:
– conjugale:
– psychologique: | 237, 440-447; 260, 76-77; 317, 15-16
202, 156-160 |
| Virus respiratoire syncytial: | 337, 6-10 |
| Vision (baisse de -): | 234, 288-290 |
Vitamine:
– B12:
– C:
– D: | 236, 384-391
289, 44-47; 296, 8-18
286, 326-329; 298, 44-50; 300, 26-34; 301, 36-44;
308, 30-33; 313, 15-16; 318, 16-17; 332, 12-14;
340, 11-13 |
| Volvulus gastrique: | 323, 18-19 |
| Vomissements: | 340, 11-13 |
| Vulvovaginite: | 292, 23-24 |
| (haut de la page) |
| Wheezing: | 337, 6-10 |
| Wolf Parkinson White: | 265, 281 |
| (haut de la page) |
| Xérostomie: | 340, 11-13 |
| (haut de la page) |
| Yersiniose: | 280, 81 |
| |
| Z-drugs: | 344, 12-13 |
| Zona: | 236, 421; 266, 341; 276, 345; 313, 17-18;
341, 13-16 |
| Zoonose: | 321, 13-14 |
| Zyka: | 338, 11-13 |
| (haut de la page) |
